CoronaVR
Experimentally proven T-cell epitopes (IEDB)
| No | Organism | Species | Protein | Epitope sequence | Start | Stop | Length | Epitope IRI | Protein IRI | Allele | MHC type | Cell type | Assay Method | Assay group | Host | PMID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SARS-related coronavirus | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 2 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A2 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 15451471 |
| 3 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A2 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15451471 |
| 4 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 15016646 |
| 5 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 15016646 |
| 6 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 15016646 |
| 7 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | 51 chromium | cytotoxicity | Homo sapiens | 15016646 |
| 8 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | 51 chromium | cytotoxicity | Homo sapiens | 15016646 |
| 9 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 15016646 |
| 10 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15016646 |
| 11 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus HLA-A2.1/Kb Tg | 15016646 |
| 12 | SARS coronavirus Tor2 | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-Kb | I | Splenocyte | ICS | IFNg release | Mus musculus C57BL/6 | 15823604 |
| 13 | SARS coronavirus Tor2 | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | Splenocyte | ICS | IFNg release | Mus musculus C57BL/6 | 15823604 |
| 14 | SARS coronavirus Tor2 | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | Splenocyte | ICS | IFNg release | Mus musculus BALB/c | 15823604 |
| 15 | SARS coronavirus Tor2 | SARS-related coronavirus | S | TSTGNYNYKYRYLRH | 431 | 445 | 15 | 66460 | P59594 | - | - | Splenocyte | bioassay | IFNg release | Mus musculus BALB/c | 15823604 |
| 16 | SARS coronavirus Tor2 | SARS-related coronavirus | S | YNYKYRYLRHGKLRP | 436 | 450 | 15 | 75238 | P59594 | - | - | Splenocyte | bioassay | IFNg release | Mus musculus BALB/c | 15823604 |
| 17 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 18 | Human coronavirus 229E | Human coronavirus 229E | S | LLLNCLWSV | 77 | 85 | 9 | 37536 | P15423 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 19 | Human coronavirus 229E | Human coronavirus 229E | S | LITGRLAAL | 881 | 889 | 9 | 36723 | P15423 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 20 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15972696 |
| 21 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15972696 |
| 22 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | PBMC | ICS | IFNg release | Homo sapiens | 15972696 |
| 23 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | PBMC | ICS | IFNg release | Homo sapiens | 15972696 |
| 24 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 15972696 |
| 25 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 15972696 |
| 26 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15972696 |
| 27 | SARS-related coronavirus | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15972696 |
| 28 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 14978121 |
| 29 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 14978121 |
| 30 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 12902505 |
| 31 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | - | - | - | in vivo assay | pathogen burden after challenge | Mus musculus C57BL/6 | 12902505 |
| 32 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | - | - | - | in vivo assay | pathogen burden after challenge | Mus musculus C57BL/6 | 12902505 |
| 33 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 12902505 |
| 34 | SARS coronavirus Urbani | SARS-related coronavirus | N | MSDNGPQSNQRSAPR | 1 | 15 | 15 | 42539 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 35 | SARS coronavirus Urbani | SARS-related coronavirus | N | PQSNQRSAPRITFGG | 6 | 20 | 15 | 49127 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 36 | SARS coronavirus Urbani | SARS-related coronavirus | N | RSAPRITFGGPTDST | 11 | 25 | 15 | 55800 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 37 | SARS coronavirus Urbani | SARS-related coronavirus | N | ITFGGPTDSTDNNQN | 16 | 30 | 15 | 28889 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 38 | SARS coronavirus Urbani | SARS-related coronavirus | N | PTDSTDNNQNGGRNG | 21 | 35 | 15 | 49606 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 39 | SARS coronavirus Urbani | SARS-related coronavirus | N | DNNQNGGRNGARPKQ | 26 | 40 | 15 | 9519 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 40 | SARS coronavirus Urbani | SARS-related coronavirus | N | ARPKQRRPQGLPNNT | 36 | 50 | 15 | 4213 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 41 | SARS coronavirus Urbani | SARS-related coronavirus | N | RRPQGLPNNTASWFT | 41 | 55 | 15 | 55683 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 42 | SARS coronavirus Urbani | SARS-related coronavirus | N | LPNNTASWFTALTQH | 46 | 60 | 15 | 38599 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 43 | SARS coronavirus Urbani | SARS-related coronavirus | N | ASWFTALTQHGKEEL | 51 | 65 | 15 | 4837 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 44 | SARS coronavirus Urbani | SARS-related coronavirus | N | ALTQHGKEELRFPRG | 56 | 70 | 15 | 2938 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 45 | SARS coronavirus Urbani | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 46 | SARS coronavirus Urbani | SARS-related coronavirus | N | ATRRVRGGDGKMKEL | 91 | 105 | 15 | 5133 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 47 | SARS coronavirus Urbani | SARS-related coronavirus | N | RGGDGKMKELSPRWY | 96 | 110 | 15 | 53873 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 48 | SARS coronavirus Urbani | SARS-related coronavirus | N | KMKELSPRWYFYYLG | 101 | 115 | 15 | 32340 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 49 | SARS coronavirus Urbani | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 50 | SARS coronavirus Urbani | SARS-related coronavirus | N | AQFAPSASAFFGMSR | 306 | 320 | 15 | 3957 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 51 | SARS coronavirus Urbani | SARS-related coronavirus | N | SASAFFGMSRIGMEV | 311 | 325 | 15 | 56980 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 52 | SARS coronavirus Urbani | SARS-related coronavirus | N | FGMSRIGMEVTPSGT | 316 | 330 | 15 | 16012 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 53 | SARS coronavirus Urbani | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 54 | SARS coronavirus Urbani | SARS-related coronavirus | N | KHIDAYKTFPPTEPK | 356 | 370 | 15 | 31115 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 55 | SARS coronavirus Urbani | SARS-related coronavirus | N | YKTFPPTEPKKDKKK | 361 | 375 | 15 | 74516 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 56 | SARS coronavirus Urbani | SARS-related coronavirus | N | PTEPKKDKKKKTDEA | 366 | 380 | 15 | 49619 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 57 | SARS coronavirus Urbani | SARS-related coronavirus | N | KDKKKKTDEAQPLPQ | 371 | 385 | 15 | 30185 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 58 | SARS coronavirus Urbani | SARS-related coronavirus | N | GAIKLDDKDPQFKDN | 336 | 350 | 15 | 18622 | P59595 | - | - | PBMC | ELISA | IFNg release | Macaca cyclopis | 16494977 |
| 59 | SARS coronavirus Urbani | SARS-related coronavirus | N | PDDQIGYYRRATRRV | 81 | 95 | 15 | 47074 | P59595 | H2-d class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB/c | 16494977 |
| 60 | SARS-related coronavirus | SARS-related coronavirus | N | NTNSGPDDQIGYYRRATR | 76 | 93 | 18 | 46198 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 61 | SARS-related coronavirus | SARS-related coronavirus | N | GPDDQIGYYRRATRRVRGGD | 80 | 99 | 20 | 21585 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 62 | SARS-related coronavirus | SARS-related coronavirus | N | GPDDQIGYYRRATRRVRGGD | 80 | 99 | 20 | 21585 | P59595 | H2-d class I | I | Splenocyte | in vitro assay | cytotoxicity | Mus musculus BALB/c | 16387339 |
| 63 | SARS-related coronavirus | SARS-related coronavirus | N | QIGYYRRATRRVRGGDGK | 84 | 101 | 18 | 51074 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 64 | SARS-related coronavirus | SARS-related coronavirus | N | TRRVRGGDGKMKELSPRW | 92 | 109 | 18 | 66094 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 65 | SARS-related coronavirus | SARS-related coronavirus | N | GKMKELSPRWYFYYL | 100 | 114 | 15 | 20633 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 66 | SARS-related coronavirus | SARS-related coronavirus | N | GIVWVATEGALNTPKDHIGT | 130 | 149 | 20 | 20485 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 67 | SARS-related coronavirus | SARS-related coronavirus | N | GIVWVATEGALNTPKDHIGT | 130 | 149 | 20 | 20485 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 16387339 |
| 68 | SARS-related coronavirus | SARS-related coronavirus | N | QQQGQTVTKKSAAEASKK | 241 | 258 | 18 | 52117 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 69 | SARS-related coronavirus | SARS-related coronavirus | N | ILLNKHIDAYKTFPP | 352 | 366 | 15 | 27183 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 70 | SARS-related coronavirus | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 71 | SARS-related coronavirus | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | H2-d class I | I | Splenocyte | in vitro assay | cytotoxicity | Mus musculus BALB/c | 16387339 |
| 72 | SARS-related coronavirus | SARS-related coronavirus | N | TWLTYHGAIKLDDKDPQF | 330 | 347 | 18 | 67276 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 73 | SARS-related coronavirus | SARS-related coronavirus | N | IKLDDKDPQFKDNVILL | 338 | 354 | 17 | 26838 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 74 | SARS-related coronavirus | SARS-related coronavirus | N | PQFKDNVILLNKHIDAYK | 345 | 362 | 18 | 48995 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 75 | SARS-related coronavirus | SARS-related coronavirus | N | IRQGTDYKHWPQIAQFA | 293 | 309 | 17 | 28371 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 76 | SARS-related coronavirus | SARS-related coronavirus | N | KHWPQIAQFAPSASAFF | 300 | 316 | 17 | 31166 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 77 | SARS-related coronavirus | SARS-related coronavirus | N | AQFAPSASAFFGMSRIGM | 306 | 323 | 18 | 3958 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 78 | SARS-related coronavirus | SARS-related coronavirus | N | AFFGMSRIGMEVTPSGTW | 314 | 331 | 18 | 1295 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 79 | SARS-related coronavirus | SARS-related coronavirus | N | GMEVTPSGTWLTYHGAIK | 322 | 339 | 18 | 21264 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 80 | SARS-related coronavirus | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 81 | SARS-related coronavirus | SARS-related coronavirus | N | YKTFPPTEPKKDKKKK | 361 | 376 | 16 | 74517 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 82 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7815531 |
| 83 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 84 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 85 | Murine hepatitis virus strain JHM | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | H2-b class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 86 | Murine hepatitis virus strain JHM | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | H2-b class II | II | T cell CD4+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 87 | Murine hepatitis virus strain JHM | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | T cell CD4+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 88 | Murine hepatitis virus strain JHM | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 89 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 90 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 91 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 16816374 |
| 92 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 16816374 |
| 93 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 16887973 |
| 94 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 16887973 |
| 95 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 96 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 97 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 98 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 99 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 100 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 101 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 102 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 103 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 104 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 105 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 106 | SARS-related coronavirus | SARS-related coronavirus | S | ILPDPLKPT | 787 | 795 | 9 | 27241 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 107 | SARS-related coronavirus | SARS-related coronavirus | S | VVFLHVTYV | 1042 | 1050 | 9 | 71663 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 108 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 109 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 110 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 111 | SARS-related coronavirus | SARS-related coronavirus | S | ILPDPLKPT | 787 | 795 | 9 | 27241 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 112 | SARS-related coronavirus | SARS-related coronavirus | S | VVFLHVTYV | 1042 | 1050 | 9 | 71663 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 113 | SARS-related coronavirus | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 114 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 115 | SARS coronavirus Urbani | SARS-related coronavirus | N | MASGGGETALALLLLDRLNQLESKV | 211 | 235 | 25 | 41122 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 17183651 |
| 116 | SARS coronavirus Urbani | SARS-related coronavirus | N | TWLTYHGAIKLDDKDPQFKDNVILL | 330 | 354 | 25 | 67277 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 17183651 |
| 117 | SARS-related coronavirus | SARS-related coronavirus | N | PTDSTDNNQNGGRNG | 21 | 35 | 15 | 49606 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 118 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 119 | SARS-related coronavirus | SARS-related coronavirus | N | PTDSTDNNQNGGRNG | 21 | 35 | 15 | 49606 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 120 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 121 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus C57BL/6 | 17392374 |
| 122 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | - | biological activity | antibody help | Mus musculus C57BL/6 | 17392374 |
| 123 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 124 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus C3H | 17392374 |
| 125 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | T cell | 3H-thymidine | proliferation | Mus musculus BALB/c | 17392374 |
| 126 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | - | biological activity | antibody help | Mus musculus C3H | 17392374 |
| 127 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 128 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus BALB/c | 17392374 |
| 129 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | - | biological activity | antibody help | Mus musculus BALB/c | 17392374 |
| 130 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | T cell | 3H-thymidine | proliferation | Mus musculus BALB/c | 17392374 |
| 131 | SARS-related coronavirus | SARS-related coronavirus | N | RSAPRITFGGPTDST | 11 | 25 | 15 | 55800 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 132 | SARS-related coronavirus | SARS-related coronavirus | N | ASWFTALTQHGKEEL | 51 | 65 | 15 | 4837 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 133 | SARS-related coronavirus | SARS-related coronavirus | N | GKEELRFPRGQGVPI | 61 | 75 | 15 | 20544 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 134 | SARS-related coronavirus | SARS-related coronavirus | N | PDDQIGYYRRATRRV | 81 | 95 | 15 | 47074 | P59595 | H2-d class II | II | T cell | 3H-thymidine | proliferation | Mus musculus BALB/c | 17392374 |
| 135 | SARS-related coronavirus | SARS-related coronavirus | N | WLTYHGAIKLDDKDP | 331 | 345 | 15 | 72815 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 136 | SARS-related coronavirus | SARS-related coronavirus | N | WLTYHGAIKLDDKDP | 331 | 345 | 15 | 72815 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 137 | SARS-related coronavirus | SARS-related coronavirus | N | ATRRVRGGDGKMKEL | 91 | 105 | 15 | 5133 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 138 | SARS-related coronavirus | SARS-related coronavirus | N | ALNTPKDHI | 139 | 147 | 9 | 2802 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 139 | SARS-related coronavirus | SARS-related coronavirus | N | LQLPQGTTL | 160 | 168 | 9 | 38881 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 140 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 141 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 142 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 143 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 144 | SARS-related coronavirus | SARS-related coronavirus | N | ILLNKHIDA | 352 | 360 | 9 | 27182 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 145 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 17629360 |
| 146 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 17629360 |
| 147 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 17629360 |
| 148 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2 class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus | 9621053 |
| 149 | SARS-related coronavirus | SARS-related coronavirus | S | GNYNYKYRYLRHGKL | 434 | 448 | 15 | 21552 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB/c | 17506989 |
| 150 | SARS coronavirus BJ01 | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 151 | SARS coronavirus BJ01 | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 152 | SARS coronavirus BJ01 | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 153 | SARS coronavirus BJ01 | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 154 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 155 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 156 | SARS coronavirus Urbani | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 17709158 |
| 157 | SARS coronavirus Urbani | SARS-related coronavirus | S | ERNFTTAPAICHEGKAYF | 1054 | 1071 | 18 | 79810 | P59594 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 17709158 |
| 158 | SARS coronavirus Urbani | SARS-related coronavirus | S | FVSGNCDVVIGIINNTVY | 1103 | 1120 | 18 | 79833 | P59594 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 17709158 |
| 159 | SARS coronavirus Urbani | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB/c | 17709158 |
| 160 | SARS coronavirus Urbani | SARS-related coronavirus | S | LMSFPQAAPHGVVFLHV | 1031 | 1047 | 17 | 38118 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 17709158 |
| 161 | SARS coronavirus Urbani | SARS-related coronavirus | S | VIGIINNTVYDPLQPEL | 1111 | 1127 | 17 | 68971 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 162 | SARS coronavirus Urbani | SARS-related coronavirus | S | VIGIINNTVYDPLQPEL | 1111 | 1127 | 17 | 68971 | P59594 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 17709158 |
| 163 | SARS coronavirus Urbani | SARS-related coronavirus | S | LMSFPQAAPHGVVFLHV | 1031 | 1047 | 17 | 38118 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 164 | SARS coronavirus Urbani | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 17709158 |
| 165 | SARS coronavirus Urbani | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 166 | SARS coronavirus Urbani | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 167 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 168 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 7494335 |
| 169 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2-Kb | I | T cell | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 7494335 |
| 170 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | Splenocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 7494335 |
| 171 | Murine hepatitis virus | Murine coronavirus | S | CSRWNGPHL | 0 | 0 | 9 | 7082 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 172 | Murine hepatitis virus | Murine coronavirus | S | CSLWSGPHL | 0 | 0 | 9 | 7034 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 173 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGLHL | 0 | 0 | 9 | 7031 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 174 | SARS-related coronavirus | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | - | - | T cell | ELISPOT | IFNg release | Mus musculus BALB/c | 18289745 |
| 175 | SARS-related coronavirus | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-d class II | II | T cell | ELISPOT | IL-4 release | Mus musculus BALB/c | 18289745 |
| 176 | SARS-related coronavirus | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-d class II | II | T cell | ELISPOT | IL-2 release | Mus musculus BALB/c | 18289745 |
| 177 | SARS-related coronavirus | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | - | - | T cell | ELISPOT | IL-10 release | Mus musculus BALB/c | 18289745 |
| 178 | SARS-related coronavirus | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | - | - | T cell | ELISPOT | IFNg release | Mus musculus BALB/c | 18289745 |
| 179 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB.B | 17913802 |
| 180 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus BALB.B | 17913802 |
| 181 | Murine hepatitis virus strain JHM | Murine coronavirus | M | VYVRPIIEDYHTLT | 134 | 147 | 14 | 72188 | P03415 | H2-b class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB.B | 17913802 |
| 182 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | Mononuclear cell | 51 chromium | cytotoxicity | Mus musculus BALB.B | 17913802 |
| 183 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | biological activity | degranulation | Mus musculus BALB.B | 17913802 |
| 184 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7558143 |
| 185 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 186 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 187 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7558143 |
| 188 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 189 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7558143 |
| 190 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 191 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7558143 |
| 192 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 193 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7558143 |
| 194 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 195 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7558143 |
| 196 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 197 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 198 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 10570300 |
| 199 | SARS-related coronavirus | SARS-related coronavirus | S | TECANLLLQYGSFCTQL | 729 | 745 | 17 | 63309 | P59594 | HLA-DR8 | II | T cell CD4+ | 51 chromium | cytotoxicity | Homo sapiens | 17692881 |
| 200 | SARS-related coronavirus | SARS-related coronavirus | S | TECANLLLQYGSFCTQL | 729 | 745 | 17 | 63309 | P59594 | HLA-DR8 | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 17692881 |
| 201 | SARS-related coronavirus | SARS-related coronavirus | S | TECANLLLQYGSFCTQL | 729 | 745 | 17 | 63309 | P59594 | HLA-DR8 | II | T cell CD4+ | ELISPOT | IFNg release | Homo sapiens | 17692881 |
| 202 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DR8 | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 17692881 |
| 203 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DR8 | II | T cell CD4+ | 51 chromium | cytotoxicity | Homo sapiens | 17692881 |
| 204 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DR8 | II | T cell CD4+ | ELISPOT | IFNg release | Homo sapiens | 17692881 |
| 205 | SARS-related coronavirus | SARS-related coronavirus | S | NIDATSTGNYNYKYRYLR | 427 | 444 | 18 | 44199 | P59594 | HLA class II | II | T cell CD4+ | 51 chromium | cytotoxicity | Homo sapiens | 17692881 |
| 206 | SARS-related coronavirus | SARS-related coronavirus | S | NIDATSTGNYNYKYRYLR | 427 | 444 | 18 | 44199 | P59594 | HLA class II | II | T cell CD4+ | ELISPOT | IFNg release | Homo sapiens | 17692881 |
| 207 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 15994805 |
| 208 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 15994805 |
| 209 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | KAVSAAGVHFKAGGPI | 186 | 201 | 16 | 29985 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 210 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | ITYKVMREVRALAYFVNGTA | 201 | 220 | 20 | 29165 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 211 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | QYNTGNFSDGLYPFTN | 237 | 252 | 16 | 53015 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 212 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | PPNSGGVNTIQLYQTKTAQ | 286 | 304 | 19 | 48846 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 213 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | GSQAIENQFYIKLTNGS | 521 | 537 | 17 | 22456 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 214 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | NCPYVSYGKFCIKPDGSIST | 8 | 27 | 20 | 43383 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 215 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | N | GYWRRQARYKPGKSG | 69 | 83 | 15 | 23501 | P69596 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 216 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | N | PAADLNWGENQDGIVWV | 100 | 116 | 17 | 46737 | P69596 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 217 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 218 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAF | 318 | 324 | 7 | 3836 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 219 | Murine hepatitis virus strain JHM | Murine coronavirus | N | TPEDRSLLA | 429 | 437 | 9 | 65539 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 220 | Murine hepatitis virus strain JHM | Murine coronavirus | N | KILNKPRQKRTPNK | 266 | 279 | 14 | 31329 | P03416 | H2-IEd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 8918920 |
| 221 | Murine hepatitis virus strain JHM | Murine coronavirus | N | KILNKPRQKRTPNK | 266 | 279 | 14 | 31329 | P03416 | H2-IEd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 8918920 |
| 222 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8627236 |
| 223 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18322201 |
| 224 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18322201 |
| 225 | Murine hepatitis virus strain JHM | Murine coronavirus | M | IDMKGTVYVRPIIE | 128 | 141 | 14 | 77913 | P03415 | H2-IAb | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 11831697 |
| 226 | Murine hepatitis virus strain JHM | Murine coronavirus | M | VYVRPIIEDYHTLT | 134 | 147 | 14 | 72188 | P03415 | H2-IAb | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 11831697 |
| 227 | Murine hepatitis virus strain JHM | Murine coronavirus | M | YVRPIIEDYHTLTA | 135 | 148 | 14 | 78085 | P03415 | H2-IAb | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 11831697 |
| 228 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 9782354 |
| 229 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 9782354 |
| 230 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | Splenocyte | 51 chromium | cytotoxicity | Mus musculus BALB/c | 10201909 |
| 231 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 10201909 |
| 232 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 10201909 |
| 233 | Murine hepatitis virus strain 4 | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 234 | Murine hepatitis virus strain 4 | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | - | - | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 | 9375010 |
| 235 | Murine hepatitis virus strain 4 | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 236 | Murine hepatitis virus strain 4 | Murine coronavirus | S | DCKIEEWLTAKSVPS | 328 | 342 | 15 | 78948 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 237 | Murine hepatitis virus strain 4 | Murine coronavirus | S | RYVQAESLSCNNIDA | 363 | 377 | 15 | 79077 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 238 | Murine hepatitis virus strain 4 | Murine coronavirus | S | SGFLQTANYKIDTAA | 408 | 422 | 15 | 79080 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 239 | Murine hepatitis virus strain 4 | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | T cell CD4+ | ELISPOT | IFNg release | Mus musculus C57BL/6 | 9375010 |
| 240 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-b class II | II | T cell CD4+ | ELISPOT | IFNg release | Mus musculus C57BL/6 | 9375010 |
| 241 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 242 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 243 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 244 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7790024 |
| 245 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7790024 |
| 246 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | T cell | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 247 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | PBMC | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 248 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | PBMC | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 249 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | PBMC | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 250 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | T cell | biological activity | antibody help | Sus scrofa | 7571447 |
| 251 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFK | 71 | 78 | 8 | 94968 | P69596 | H2-IEd | II | T cell CD4+ | bioassay | IL-2 release | Mus musculus | 1718856 |
| 252 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFK | 71 | 78 | 8 | 94968 | P69596 | H2-IEd | II | T cell CD4+ | bioassay | IL-2 release | Mus musculus | 1718856 |
| 253 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | QHGYWRRQARFKPGKGG | 67 | 83 | 17 | 94903 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 254 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | QHGYWRRQARFKPGKGG | 67 | 83 | 17 | 94903 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 255 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | QHGYWRRQARFKPGKGG | 67 | 83 | 17 | 94903 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 256 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFKPGKGG | 71 | 83 | 13 | 94969 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 257 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFKPGKGG | 71 | 83 | 13 | 94969 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 258 | Murine hepatitis virus strain JHM | Murine coronavirus | N | GLAPTAGAFFFGSKL | 0 | 0 | 15 | 96324 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 259 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 260 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 261 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 262 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 263 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 264 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 265 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 266 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 267 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 268 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 269 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 7790024 |
| 270 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 271 | Murine hepatitis virus | Murine coronavirus | S | CSLWSGPHL | 0 | 0 | 9 | 7034 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 272 | Murine hepatitis virus | Murine coronavirus | S | CFLWNGPHL | 0 | 0 | 9 | 98709 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 273 | Murine hepatitis virus | Murine coronavirus | S | CPLWNGPHL | 0 | 0 | 9 | 98712 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 274 | Murine hepatitis virus | Murine coronavirus | S | CSFWNGPHL | 0 | 0 | 9 | 98714 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 275 | Murine hepatitis virus | Murine coronavirus | S | CSPWNGPHL | 0 | 0 | 9 | 98720 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 276 | Murine hepatitis virus | Murine coronavirus | S | CSLWHGPHL | 0 | 0 | 9 | 98716 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 277 | Murine hepatitis virus | Murine coronavirus | S | CSLWDGPHL | 0 | 0 | 9 | 98715 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 278 | Murine hepatitis virus | Murine coronavirus | S | CSLWTGPHL | 0 | 0 | 9 | 98719 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 279 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGHHL | 0 | 0 | 9 | 98717 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 280 | Murine hepatitis virus | Murine coronavirus | S | ECSWNGPHL | 0 | 0 | 9 | 98745 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 281 | SARS-related coronavirus | SARS-related coronavirus | S | VRGWVFGSTMNNKSQSVI | 98 | 115 | 18 | 100627 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 282 | SARS-related coronavirus | SARS-related coronavirus | S | CTFEYISDAFSLD | 159 | 171 | 13 | 99918 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 283 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 284 | SARS-related coronavirus | SARS-related coronavirus | S | TNFRAILTAFSPAQDIW | 229 | 245 | 17 | 100567 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 285 | SARS-related coronavirus | SARS-related coronavirus | S | CSQNPLAELKCSVKSFEI | 278 | 295 | 18 | 7065 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 286 | SARS-related coronavirus | SARS-related coronavirus | S | KSFEIDKGIYQTSNFRVV | 291 | 308 | 18 | 33305 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 287 | SARS-related coronavirus | SARS-related coronavirus | S | KKISNCVADYSVLYNSTF | 343 | 360 | 18 | 31582 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 288 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 289 | SARS-related coronavirus | SARS-related coronavirus | S | KSIVAYTMSLGADSSIAY | 672 | 689 | 18 | 100230 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 290 | SARS-related coronavirus | SARS-related coronavirus | S | VKQMYKTPTLKYFGGFNF | 767 | 784 | 18 | 100612 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 291 | SARS-related coronavirus | SARS-related coronavirus | S | GFMKQYGECLGDINARDL | 814 | 831 | 18 | 100057 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 292 | SARS-related coronavirus | SARS-related coronavirus | S | MAYRFNGIGVTQNVLY | 884 | 899 | 16 | 100300 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 293 | SARS-related coronavirus | SARS-related coronavirus | S | ESLTTTSTALGKLQDVV | 918 | 934 | 17 | 14208 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 294 | SARS-related coronavirus | SARS-related coronavirus | S | QALNTLVKQLSSNFGAI | 939 | 955 | 17 | 50311 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 295 | SARS-related coronavirus | SARS-related coronavirus | S | QLIRAAEIRASANLAATK | 993 | 1010 | 18 | 100428 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 296 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 297 | SARS-related coronavirus | SARS-related coronavirus | S | EIFRSDTLYLTQDLFLPF | 45 | 62 | 18 | 99995 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 298 | SARS-related coronavirus | SARS-related coronavirus | S | YLTQDLFLPFYSNVTGFH | 53 | 70 | 18 | 100665 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 299 | SARS-related coronavirus | SARS-related coronavirus | S | TGFHTINHTFGNPVIPFK | 67 | 84 | 18 | 100553 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 300 | SARS-related coronavirus | SARS-related coronavirus | S | TLKPIFKLPLGINITNFR | 215 | 232 | 18 | 100561 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 301 | SARS-related coronavirus | SARS-related coronavirus | S | TAFSPAQDIWGTSAAAYF | 236 | 253 | 18 | 100541 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 302 | SARS-related coronavirus | SARS-related coronavirus | S | KSFEIDKGIYQTSNFRVV | 291 | 308 | 18 | 33305 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 303 | SARS-related coronavirus | SARS-related coronavirus | S | IYQTSNFRVVPSGDVVRF | 299 | 316 | 18 | 29666 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 304 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 305 | SARS-related coronavirus | SARS-related coronavirus | S | LLRSTSQKSIVAYTMSL | 665 | 681 | 17 | 37758 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 306 | SARS-related coronavirus | SARS-related coronavirus | S | KSIVAYTMSLGADSSIAY | 672 | 689 | 18 | 100230 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 307 | SARS-related coronavirus | SARS-related coronavirus | S | AQKFNGLTVLPPLLTDDM | 834 | 851 | 18 | 99899 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 308 | SARS-related coronavirus | SARS-related coronavirus | S | GAALQIPFAMQMAYRF | 873 | 888 | 16 | 100048 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 309 | SARS-related coronavirus | SARS-related coronavirus | S | CTFEYISDAFSLD | 159 | 171 | 13 | 99918 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 310 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 311 | SARS-related coronavirus | SARS-related coronavirus | S | KSFEIDKGIYQTSNFRVV | 291 | 308 | 18 | 33305 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 312 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 313 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 314 | SARS-related coronavirus | SARS-related coronavirus | S | CTFEYISDAFSLD | 159 | 171 | 13 | 99918 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 315 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 316 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 317 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 318 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IFNg release | Homo sapiens | 19050106 |
| 319 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IFNg release | Homo sapiens | 19050106 |
| 320 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IFNg release | Homo sapiens | 19050106 |
| 321 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-13 release | Homo sapiens | 19050106 |
| 322 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-13 release | Homo sapiens | 19050106 |
| 323 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-10 release | Homo sapiens | 19050106 |
| 324 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-10 release | Homo sapiens | 19050106 |
| 325 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-5 release | Homo sapiens | 19050106 |
| 326 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-5 release | Homo sapiens | 19050106 |
| 327 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-13 release | Homo sapiens | 19050106 |
| 328 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-10 release | Homo sapiens | 19050106 |
| 329 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-5 release | Homo sapiens | 19050106 |
| 330 | SARS coronavirus Tor2 | SARS-related coronavirus | ORF 3a | PLQASLPFGWLVIGV | 36 | 50 | 15 | 101126 | P59632 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 331 | SARS coronavirus Tor2 | SARS-related coronavirus | S | NYNYKYRYLRHGKLRPF | 435 | 451 | 17 | 46681 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 332 | SARS coronavirus Tor2 | SARS-related coronavirus | S | AGCLIGAEHVDTSYECDI | 633 | 650 | 18 | 100711 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 333 | SARS coronavirus Tor2 | SARS-related coronavirus | N | GETALALLLLDRLNQ | 216 | 230 | 15 | 19443 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 334 | SARS coronavirus Tor2 | SARS-related coronavirus | M | GHLRMAGHSLGRCDI | 146 | 160 | 15 | 100879 | P59596 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 335 | SARS coronavirus Tor2 | SARS-related coronavirus | S | NFNGLTGTGVLTPSSKRF | 528 | 545 | 18 | 43894 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 336 | SARS coronavirus Tor2 | SARS-related coronavirus | S | DIPIGAGICASYHTVSLL | 649 | 666 | 18 | 100778 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 337 | SARS coronavirus Tor2 | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 338 | SARS-related coronavirus | SARS-related coronavirus | S | YLRHGKLRPFERDISNVP | 442 | 459 | 18 | 100664 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 339 | SARS-related coronavirus | SARS-related coronavirus | S | YLRHGKLRPFERDISNVP | 442 | 459 | 18 | 100664 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 340 | SARS-related coronavirus | SARS-related coronavirus | S | YLRHGKLRPFERDISNVP | 442 | 459 | 18 | 100664 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 341 | SARS-related coronavirus | SARS-related coronavirus | S | NAFNCTFEYISDAFSLDV | 155 | 172 | 18 | 100316 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 342 | SARS-related coronavirus | SARS-related coronavirus | S | NPFFAVSKPMGTQTHTMI | 135 | 152 | 18 | 100347 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 343 | SARS-related coronavirus | SARS-related coronavirus | S | QLIRAAEIRASANLAATK | 993 | 1010 | 18 | 100428 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 344 | SARS-related coronavirus | SARS-related coronavirus | S | VRGWVFGSTMNNKSQSVI | 98 | 115 | 18 | 100627 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 345 | SARS-related coronavirus | SARS-related coronavirus | S | TNFRAILTAFSPAQDIW | 229 | 245 | 17 | 100567 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 346 | SARS-related coronavirus | SARS-related coronavirus | S | ESLTTTSTALGKLQDVV | 918 | 934 | 17 | 14208 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 347 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 348 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 349 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 350 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 351 | SARS coronavirus Urbani | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 352 | SARS coronavirus Urbani | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 353 | SARS coronavirus Urbani | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 354 | SARS coronavirus Urbani | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 355 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 356 | SARS coronavirus Urbani | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 357 | SARS coronavirus Urbani | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 358 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | - | in vivo assay | pathogen burden after challenge | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 359 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 12692247 |
| 360 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | GM-CSF release | Homo sapiens | 12692247 |
| 361 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | GM-CSF release | Homo sapiens | 12692247 |
| 362 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | GM-CSF release | Homo sapiens | 12692247 |
| 363 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 364 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 365 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 366 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 367 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 368 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 369 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | - | - | Splenocyte | cytometric bead array | IFNg release | Mus musculus SJL | 17376542 |
| 370 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | - | - | Splenocyte | cytometric bead array | IFNg release | Mus musculus SJL | 17376542 |
| 371 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 372 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 373 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 374 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 375 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 376 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 377 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | - | - | Splenocyte | cytometric bead array | IFNg release | Mus musculus SJL | 17376542 |
| 378 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | 3H-thymidine | proliferation | Mus musculus SJL | 9759846 |
| 379 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | 3H-thymidine | proliferation | Mus musculus SJL | 9759846 |
| 380 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IFNg release | Mus musculus SJL | 9759846 |
| 381 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IL-2 release | Mus musculus SJL | 9759846 |
| 382 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IFNg release | Mus musculus SJL | 9759846 |
| 383 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IL-2 release | Mus musculus SJL | 9759846 |
| 384 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | - | in vivo assay | disease exacerbation | Mus musculus SJL | 9759846 |
| 385 | SARS-related coronavirus | SARS-related coronavirus | S | ALNTLVKQL | 940 | 948 | 9 | 2801 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 386 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 387 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 388 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 389 | SARS-related coronavirus | SARS-related coronavirus | S | ALNTLVKQL | 940 | 948 | 9 | 2801 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 390 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 391 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 392 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 393 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 394 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 395 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 396 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 397 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 398 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 399 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | CLDAGINYV | 2187 | 2195 | 9 | 6543 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 400 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | AMWLLLLSI | 2207 | 2215 | 9 | 3212 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 401 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | WLMWFIISI | 2340 | 2348 | 9 | 72761 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 402 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ILLLDQVLV | 2546 | 2554 | 9 | 27170 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 403 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | LLCVLAALV | 2755 | 2763 | 9 | 120069 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 404 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ALSGVFCGV | 2990 | 2998 | 9 | 2880 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 405 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | VLAWLYAAV | 3444 | 3452 | 9 | 69392 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 406 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | TLMNVITLV | 3687 | 3695 | 9 | 64955 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 407 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | SMWALVISV | 3709 | 3717 | 9 | 59776 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 408 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | H2 class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 409 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | CLDAGINYV | 2187 | 2195 | 9 | 6543 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 410 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | WLMWFIISI | 2340 | 2348 | 9 | 72761 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 411 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ILLLDQVLV | 2546 | 2554 | 9 | 27170 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 412 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | LLCVLAALV | 2755 | 2763 | 9 | 120069 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 413 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ALSGVFCGV | 2990 | 2998 | 9 | 2880 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 414 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | TLMNVITLV | 3687 | 3695 | 9 | 64955 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 415 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | SMWALVISV | 3709 | 3717 | 9 | 59776 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 416 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 417 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | CLDAGINYV | 2187 | 2195 | 9 | 6543 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 418 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | WLMWFIISI | 2340 | 2348 | 9 | 72761 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 419 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ILLLDQVLV | 2546 | 2554 | 9 | 27170 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 420 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | LLCVLAALV | 2755 | 2763 | 9 | 120069 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 421 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ALSGVFCGV | 2990 | 2998 | 9 | 2880 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 422 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | TLMNVITLV | 3687 | 3695 | 9 | 64955 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 423 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | SMWALVISV | 3709 | 3717 | 9 | 59776 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 424 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RFPRGQGVPINTNSGPDDQI | 66 | 85 | 20 | 53758 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 425 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NTNSGPDDQIGYYRRATR | 76 | 93 | 18 | 46198 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 426 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | QIGYYRRATRRVRGGDGK | 84 | 101 | 18 | 51074 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 427 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | TRRVRGGDGKMKELSPRW | 92 | 109 | 18 | 66094 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 428 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GKMKELSPRWYFYYL | 100 | 114 | 15 | 20633 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 429 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | LSPRWYFYYLGTGPEASL | 105 | 122 | 18 | 39577 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 430 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YLGTGPEASLPYGANK | 113 | 128 | 16 | 74684 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 431 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | ANKEGIVWVATEGAL | 126 | 140 | 15 | 3324 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 432 | SARS-related coronavirus | SARS-related coronavirus | N | PKGFYAEGSRGGSQASSR | 169 | 186 | 18 | 48067 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 433 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MASGGGETALALLLLDRL | 211 | 228 | 18 | 41120 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 434 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | QQQGQTVTKKSAAEASKK | 241 | 258 | 18 | 52117 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 435 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SKKPRQKRTATKQYNV | 256 | 271 | 16 | 58868 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 436 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | KHWPQIAQFAPSASAFF | 300 | 316 | 17 | 31166 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 437 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | AFFGMSRIGMEVTPSGTW | 314 | 331 | 18 | 1295 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 438 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PQFKDNVILLNKHIDAYK | 345 | 362 | 18 | 48995 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 439 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 440 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 441 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 442 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 443 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 444 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 445 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 446 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 447 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 448 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 449 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 450 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 451 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 452 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 453 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 454 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 455 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 456 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 457 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 458 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 459 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 460 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 461 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 462 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 463 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 464 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 465 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 466 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 467 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 468 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 469 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 470 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 471 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 472 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 473 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 474 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 475 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 476 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 477 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 478 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 479 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 480 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 481 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 482 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 483 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 484 | SARS-related coronavirus | SARS-related coronavirus | N | ILLNKHID | 352 | 359 | 8 | 125100 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 485 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 486 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 487 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 488 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 489 | SARS-related coronavirus | SARS-related coronavirus | N | LQLPQGTTL | 160 | 168 | 9 | 38881 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 490 | SARS-related coronavirus | SARS-related coronavirus | N | ALNTPKDHI | 139 | 147 | 9 | 2802 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 491 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 492 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 493 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 494 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 495 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 496 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 497 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | - | in vivo assay | pathogen burden after challenge | Mus musculus C57BL/6 | 18949029 |
| 498 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 18949029 |
| 499 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 500 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 18949029 |
| 501 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 502 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 18949029 |
| 503 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 504 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | IGNITLALGKVSNAITTTSD | 1089 | 1108 | 20 | 139083 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 505 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | GKVSNAITTTSDGFNSMASA | 1097 | 1116 | 20 | 139063 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 506 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | GKVSNAITTTSDGFNSMASA | 1097 | 1116 | 20 | 139063 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 507 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | QSVVNQQGEALSQLTSQLQK | 1121 | 1140 | 20 | 139212 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 508 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | EALSQLTSQLQKNFQAISSS | 1129 | 1148 | 20 | 139032 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 509 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | QLQKNFQAISSSIAEIYNRL | 1137 | 1156 | 20 | 139206 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 510 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | YNRLEKVEADAQVDRLITGR | 1153 | 1172 | 20 | 139407 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 511 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | YNRLEKVEADAQVDRLITGR | 1153 | 1172 | 20 | 139407 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 512 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ITGRLAALNAYVSQTLTQY | 1169 | 1187 | 19 | 139100 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 513 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | FSLVNSAPEGLLFFHTVLLPTEWEEVTA | 1222 | 1249 | 28 | 139054 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 514 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | FSLVNSAPEGLLFFHTVLLPTEWEEVTA | 1222 | 1249 | 28 | 139054 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 515 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | WSGICVNDTYAYVLKDFDHSIFSYNGTY | 1250 | 1277 | 28 | 139392 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 516 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | TFQEIVIDYIDINKTIADML | 1312 | 1331 | 20 | 139313 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 517 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | YIDINKTIADMLEQYNPNYT | 1320 | 1339 | 20 | 139404 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 518 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ADMLEQYNPNYTTPELNLL | 1328 | 1346 | 19 | 138985 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 519 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | PNYTTPELNLLLDIFNQTKL | 1336 | 1355 | 20 | 139193 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 520 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | EIDQLEQRADNLTTIAHELQ | 1360 | 1379 | 20 | 139034 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 521 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ADNLTTIAHELQQYIDNLNK | 1368 | 1387 | 20 | 138986 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 522 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | LDWLNRIETYVKWPWYVWLL | 1392 | 1411 | 20 | 139159 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 523 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | LDWLNRIETYVKWPWYVWLL | 1392 | 1411 | 20 | 139159 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 524 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20844028 |
| 525 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20844028 |
| 526 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 20844028 |
| 527 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | PBMC | CFSE | proliferation | Homo sapiens | 20844028 |
| 528 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 529 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 530 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 531 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 532 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 533 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 534 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 20831383 |
| 535 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 20831383 |
| 536 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20831383 |
| 537 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20831383 |
| 538 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | NYVALQTDVLQENQKILANA | 1065 | 1084 | 20 | 139192 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 539 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | VLQENQKILANAFNNAIGNI | 1073 | 1092 | 20 | 139359 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 540 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | IGNITLALGKVSNAITTTSD | 1089 | 1108 | 20 | 139083 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 541 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | TTSDGFNSMASALTKIQSVV | 1105 | 1124 | 20 | 139330 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 542 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ITGRLAALNAYVSQTLTQY | 1169 | 1187 | 19 | 139100 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 543 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | FSLVNSAPEGLLFFHTVLLPTEWEEVTA | 1222 | 1249 | 28 | 139054 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 544 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | QALSHLTVQLQNNFQAISSS | 1115 | 1134 | 20 | 142260 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 545 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | ISSSISDIYNRLDELSADAQ | 1131 | 1150 | 20 | 142189 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 546 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | ITGRLTALNAFVSQTLTRQA | 1155 | 1174 | 20 | 142190 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 547 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | FSLANAAPNGMIFFHTVLLPTAYETVTAW | 1208 | 1236 | 29 | 142156 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 548 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | WSGICASDGDRTFGLVVKDVQLTLFRNLDDKF | 1236 | 1267 | 32 | 142331 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 549 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | EIDDLEFRSEKLHNTTVELA | 1348 | 1367 | 20 | 142140 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 550 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NINNTLVNLEWLNRIETYVK | 1372 | 1391 | 20 | 142240 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 551 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | YVCPRDFVPKGIGNKDQQIG | 49 | 68 | 20 | 142341 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 552 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | YVCPRDFVPKGIGNKDQQIG | 49 | 68 | 20 | 142341 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 553 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | GQRKELPERWFFYFLGTGPH | 81 | 100 | 20 | 142171 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 554 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | GQRKELPERWFFYFLGTGPH | 81 | 100 | 20 | 142171 | P25909 | H2 class I | I | T cell CD8+ | ELISA | IFNg release | Felis catus | 21216312 |
| 555 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | EPLRFDGKIPPQFQLEVNRS | 137 | 156 | 20 | 142145 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 556 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | EPLRFDGKIPPQFQLEVNRS | 137 | 156 | 20 | 142145 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 557 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | IPPQFQLEVNRSRNNSRSGS | 145 | 164 | 20 | 142187 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 558 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | IPPQFQLEVNRSRNNSRSGS | 145 | 164 | 20 | 142187 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 559 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | DVTNFFGARSASANFGDSDL | 241 | 260 | 20 | 142133 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 560 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | IAECVPSVSSVLFGSQWSAE | 273 | 292 | 20 | 142182 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 561 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | AKTSQFLEQIDAYKRPSQVA | 313 | 332 | 20 | 142110 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 562 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | SVTLVEAYTDVFDDTQVEMI | 353 | 372 | 20 | 142304 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 563 | SARS-related coronavirus | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20610717 |
| 564 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20610717 |
| 565 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 20610717 |
| 566 | SARS-related coronavirus | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNF release | Mus musculus C57BL/6 | 20610717 |
| 567 | SARS-related coronavirus | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 20610717 |
| 568 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNF release | Mus musculus C57BL/6 | 20610717 |
| 569 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 20610717 |
| 570 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | TNF release | Mus musculus BALB/c | 20610717 |
| 571 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus BALB/c | 20610717 |
| 572 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 20610717 |
| 573 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 20610717 |
| 574 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 20610717 |
| 575 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | TNF release | Mus musculus BALB/c | 20610717 |
| 576 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 20610717 |
| 577 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | in vivo assay | cytotoxicity | Mus musculus BALB/c | 20610717 |
| 578 | Feline coronavirus | Alphacoronavirus 1 | N | RLGVTSDNKQ | 199 | 208 | 10 | 144946 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21376481 |
| 579 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 21525347 |
| 580 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IL-10 release | Mus musculus C57BL/6 | 21525347 |
| 581 | Murine hepatitis virus | Murine coronavirus | S | TTYDLRCL | 532 | 539 | 8 | 147348 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 582 | Murine hepatitis virus | Murine coronavirus | S | RCHIFSNLL | 587 | 595 | 9 | 147241 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 583 | Murine hepatitis virus | Murine coronavirus | S | LTTFEPFTVSIVNDS | 766 | 780 | 15 | 147122 | P11224 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 584 | Murine hepatitis virus | Murine coronavirus | S | IDDINFSPLLGCLGS | 881 | 895 | 15 | 147025 | P11224 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 585 | Murine hepatitis virus | Murine coronavirus | S | LSDVGFVEAYNNCTG | 921 | 935 | 15 | 147114 | P11224 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 586 | Murine hepatitis virus | Murine coronavirus | S | GGNSIIGFWHTDIKS | 171 | 185 | 15 | 146966 | P11224 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 587 | Murine hepatitis virus | Murine coronavirus | S | VGLVYRRV | 317 | 324 | 8 | 147369 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 588 | Murine hepatitis virus | Murine coronavirus | S | SLLRFVQAESLSCSN | 361 | 375 | 15 | 147293 | P11224 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 589 | Murine hepatitis virus | Murine coronavirus | N | DVYELQYSGAIRFDS | 346 | 360 | 15 | 146856 | P03416 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 590 | Murine hepatitis virus | Murine coronavirus | N | LDAYQDQAGGADVVS | 376 | 390 | 15 | 147085 | P03416 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 591 | Murine hepatitis virus | Murine coronavirus | N | QRNVSREL | 421 | 428 | 8 | 147235 | P03416 | H2-Dk | I | T cell CD8+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 592 | Murine hepatitis virus | Murine coronavirus | M | KGTVYVRPIIEDYHT | 131 | 145 | 15 | 147062 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 593 | Murine hepatitis virus | Murine coronavirus | M | CTYKRAFL | 184 | 191 | 8 | 146810 | P03415 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 594 | Murine hepatitis virus | Murine coronavirus | M | GVSGFAVYVKSKVGN | 196 | 210 | 15 | 147006 | P03415 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 595 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus SJL | 16981179 |
| 596 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus SJL | 16981179 |
| 597 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus SJL | 16981179 |
| 598 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | TMLSLATAKVIAKWLAVNVLYFTDVPQIKL | 3811 | 3840 | 30 | 149122 | P0C6X9 | H2-s class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus SJL | 16981179 |
| 599 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus SJL | 16981179 |
| 600 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 601 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 602 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | AFLAVFQSATKIIAL | 51 | 65 | 15 | 156841 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 603 | SARS-related coronavirus | SARS-related coronavirus | N | TPSGTWLTYHGAIKL | 326 | 340 | 15 | 65764 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 604 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | GVKDYVVVHGYFTEV | 196 | 210 | 15 | 156880 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 605 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | YFTEVYYQLESTQIT | 206 | 220 | 15 | 156976 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 606 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | NKRWQLALYKGFQFI | 66 | 80 | 15 | 156921 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 607 | SARS-related coronavirus | SARS-related coronavirus | N | IGMEVTPSGTWLTYH | 321 | 335 | 15 | 26273 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 608 | SARS-related coronavirus | SARS-related coronavirus | N | ANKEGIVWVATEGAL | 126 | 140 | 15 | 3324 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 609 | SARS-related coronavirus | SARS-related coronavirus | N | AQFAPSASAFFGMSR | 306 | 320 | 15 | 3957 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 610 | SARS-related coronavirus | SARS-related coronavirus | N | RRPQGLPNNTASWFT | 41 | 55 | 15 | 55683 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 611 | SARS-related coronavirus | SARS-related coronavirus | N | KMKELSPRWYFYYLG | 101 | 115 | 15 | 32340 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 612 | SARS-related coronavirus | SARS-related coronavirus | N | QKRTATKQYNVTQAF | 261 | 275 | 15 | 51250 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 613 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 614 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | TNFa release | Homo sapiens | 21813600 |
| 615 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | IL-2 release | Homo sapiens | 21813600 |
| 616 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | CCL3/MIP-1a release | Homo sapiens | 21813600 |
| 617 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | CCL4/MIP-1b release | Homo sapiens | 21813600 |
| 618 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | GM-CSF release | Homo sapiens | 21813600 |
| 619 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | TNFa release | Homo sapiens | 21813600 |
| 620 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | CCL3/MIP-1a release | Homo sapiens | 21813600 |
| 621 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | CCL4/MIP-1b release | Homo sapiens | 21813600 |
| 622 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IL-2 release | Homo sapiens | 21813600 |
| 623 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 21813600 |
| 624 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 21813600 |
| 625 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | GM-CSF release | Homo sapiens | 21813600 |
| 626 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IL-8 release | Homo sapiens | 21813600 |
| 627 | Murine hepatitis virus strain A59 | Murine coronavirus | S | RCQIFANI | 546 | 553 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 14722270 |
| 628 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFFGSKLELVKK | 318 | 335 | 18 | 156540 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7815531 |
| 629 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 7815531 |
| 630 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | IL-8 release | Homo sapiens | 21813600 |
| 631 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFFGSKLELVKK | 318 | 335 | 18 | 156540 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7815531 |
| 632 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | - | in vivo assay | pathogen burden after challenge | Mus musculus BALB/c | 7815531 |
| 633 | SARS-related coronavirus | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-Kd | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 22963340 |
| 634 | SARS-related coronavirus | SARS-related coronavirus | S | YGVSATKL | 367 | 374 | 8 | 181163 | P59594 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 22963340 |
| 635 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 22105170 |
| 636 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 22105170 |
| 637 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | - | in vivo assay | cytotoxicity | Mus musculus C57BL/6 | 22105170 |
| 638 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 22915814 |
| 639 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-Kb | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 22915814 |
| 640 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 23928495 |
| 641 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 23928495 |
| 642 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IL-10 release | Mus musculus C57BL/6 | 23928495 |
| 643 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 23280567 |
| 644 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 23280567 |
| 645 | SARS-related coronavirus | SARS-related coronavirus | N | MEVTPSGTWL | 323 | 332 | 10 | 190494 | P59595 | HLA-B*40:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 23280567 |
| 646 | SARS-related coronavirus | SARS-related coronavirus | N | MEVTPSGTWL | 323 | 332 | 10 | 190494 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 23280567 |
| 647 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | SITAQPVKI | 12 | 20 | 9 | 193551 | P59632 | HLA-B*58:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 23280567 |
| 648 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | SITAQPVKI | 12 | 20 | 9 | 193551 | P59632 | HLA-B*58:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 23280567 |
| 649 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 650 | SARS-related coronavirus | SARS-related coronavirus | N | MEVTPSGTWL | 323 | 332 | 10 | 190494 | P59595 | HLA-B*40:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 651 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA-B*58:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 652 | SARS-related coronavirus | SARS-related coronavirus | N | RRPQGLPNNIASWFT | 41 | 55 | 15 | 190533 | P59595 | HLA-B*55:02 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 653 | SARS-related coronavirus | SARS-related coronavirus | N | QKRTATKQYNVTQAF | 261 | 275 | 15 | 51250 | P59595 | HLA-B*15:25 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 654 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | GHFYINGYNFFSTFPIGCIS | 431 | 450 | 20 | 226034 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 655 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | SVVLLPSFFTYTAVNITIDL | 521 | 540 | 20 | 226106 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 656 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | YTAVNITIDLGMKLSGYGQP | 531 | 550 | 20 | 226133 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 657 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | CIRSNQFSVYVHSTCKSSLW | 571 | 590 | 20 | 226011 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 658 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | GTCPFSFDKLNNYLTFNKFC | 611 | 630 | 20 | 226038 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 659 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NNYLTFNKFCLSLSPVGANC | 621 | 640 | 20 | 226076 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 660 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NEQVVRSLYVIYEEGDNIVG | 651 | 670 | 20 | 226074 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 661 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | MKYVVFILACILACAFGERY | 1 | 20 | 20 | 226071 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 662 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VILIVFITVLQYGRPQFSWL | 61 | 80 | 20 | 226118 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 663 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | QYGRPQFSWLVYGIKMLIMW | 71 | 90 | 20 | 226093 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 664 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | IFNAYSEYQVSRYVMFGFSV | 101 | 120 | 20 | 226043 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 665 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | MMYFVRSIQLYRRTKSWWSF | 131 | 150 | 20 | 226072 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 666 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | YRRTKSWWSFNPETNAILCV | 141 | 160 | 20 | 226132 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 667 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | NPETNAILCVNAVGRSYVLP | 151 | 170 | 20 | 226077 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 668 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | NAVGRSYVLPLDGTPTGVTL | 161 | 180 | 20 | 226073 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 669 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | LDGTPTGVTLTLLSGNLYAE | 171 | 190 | 20 | 226059 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 670 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | TLLSGNLYAEGFKMAGGLTI | 181 | 200 | 20 | 226112 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 671 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | EHLPKYVMIATPSRTIVYTL | 201 | 220 | 20 | 226017 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 672 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | TPSRTIVYTLVGKQLKATTA | 211 | 230 | 20 | 226114 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 673 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | QYGRPQFSWLVYGIKMLIMW | 71 | 90 | 20 | 226093 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 674 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | IFNAYSEYQVSRYVMFGFSV | 101 | 120 | 20 | 226043 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 675 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | MMYFVRSIQLYRRTKSWWSF | 131 | 150 | 20 | 226072 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 676 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | IGNITLALGKVSNAITTTSD | 1089 | 1108 | 20 | 139083 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 677 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ITGRLAALNAYVSQTLTQY | 1169 | 1187 | 19 | 139100 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 678 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | HLANWNFSWSVILIVFITVL | 51 | 70 | 20 | 226041 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 679 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VYGIKMLIMWLLWPIVLALT | 81 | 100 | 20 | 226128 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 680 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | SRYVMFGFSVAGAVVTFALW | 111 | 130 | 20 | 226103 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 681 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | AGAVVTFALWMMYFVRSIQL | 121 | 140 | 20 | 226001 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 682 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | GHFYINGYNFFSTFPIGCIS | 431 | 450 | 20 | 226034 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 683 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NNYLTFNKFCLSLSPVGANC | 621 | 640 | 20 | 226076 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 684 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | HLANWNFSWSVILIVFITVL | 51 | 70 | 20 | 226041 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 685 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VYGIKMLIMWLLWPIVLALT | 81 | 100 | 20 | 226128 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 686 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | SRYVMFGFSVAGAVVTFALW | 111 | 130 | 20 | 226103 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 687 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | AGAVVTFALWMMYFVRSIQL | 121 | 140 | 20 | 226001 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 688 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | GQRKELPERWFFYFLGTGPH | 81 | 100 | 20 | 142171 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 689 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | EPLRFDGKIPPQFQLEVNRS | 137 | 156 | 20 | 142145 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 690 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NNYLTFNKFCLSLSPVGANC | 621 | 640 | 20 | 226076 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 691 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VYGIKMLIMWLLWPIVLALT | 81 | 100 | 20 | 226128 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 692 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 693 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 694 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 695 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 696 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 697 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 698 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 699 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 700 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 701 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 25056892 |
| 702 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 703 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 25056892 |
| 704 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25056892 |
| 705 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25056892 |
| 706 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 707 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 708 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 709 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 710 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | intracellular staining | granzyme B release | Mus musculus C57BL/6 | 25056892 |
| 711 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | in vivo assay | cytotoxicity | Mus musculus C57BL/6 | 25056892 |
| 712 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | intracellular staining | granzyme B release | Mus musculus C57BL/6 | 25056892 |
| 713 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | in vivo assay | cytotoxicity | Mus musculus C57BL/6 | 25056892 |
| 714 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | - | in vivo assay | survival from challenge | Mus musculus C57BL/6 | 25056892 |
| 715 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | - | in vivo assay | survival from challenge | Mus musculus C57BL/6 | 25056892 |
| 716 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25135637 |
| 717 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25135637 |
| 718 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL + (C1) | 510 | 518 | 16 | 422251 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25135637 |
| 719 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25135637 |
| 720 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL + (C1) | 510 | 518 | 16 | 422251 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25135637 |
| 721 | Infectious bronchitis virus | Avian coronavirus | S | SRIQTATDP | 412 | 420 | 9 | 502625 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 722 | Infectious bronchitis virus | Avian coronavirus | S | SRNATGSQP | 516 | 524 | 9 | 502630 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 723 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | GAYAVVNV | 45 | 52 | 8 | 499027 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 724 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | SRIQTATQP | 413 | 421 | 9 | 502627 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 725 | Infectious bronchitis virus | Avian coronavirus | S | SRIQTATDP | 412 | 420 | 9 | 502625 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 726 | Infectious bronchitis virus | Avian coronavirus | S | SRNATGSQP | 516 | 524 | 9 | 502630 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 727 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | GAYAVVNV | 45 | 52 | 8 | 499027 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 728 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | SRIQTATQP | 413 | 421 | 9 | 502627 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 729 | Infectious bronchitis virus | Avian coronavirus | S | NQFYIKLT | 527 | 534 | 8 | 509285 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus H.B15 | 26876645 |
| 730 | Infectious bronchitis virus | Avian coronavirus | S | NQFYIKLT | 527 | 534 | 8 | 509285 | P11223 | chicken class I | I | T cell CD8+ | RNA/DNA detection | IFNg release | Gallus gallus H.B15 | 26876645 |
| 731 | SARS-related coronavirus | SARS-related coronavirus | N | KMKELSPRWYFYYLG | 101 | 115 | 15 | 32340 | P59595 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 732 | SARS-related coronavirus | SARS-related coronavirus | M | HLRMAGHSL | 147 | 155 | 9 | 532115 | P59596 | HLA class I | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 733 | SARS-related coronavirus | SARS-related coronavirus | S | STDLIKNQCVNFNFN | 516 | 530 | 15 | 61554 | P59594 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 734 | SARS-related coronavirus | SARS-related coronavirus | S | SSKRFQPFQQFGRDV | 541 | 555 | 15 | 533900 | P59594 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 735 | SARS-related coronavirus | SARS-related coronavirus | S | GTSWFITQRNFFSPQ | 1081 | 1095 | 15 | 532052 | P59594 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 736 | SARS-related coronavirus | SARS-related coronavirus | M | HLRMAGHSL | 147 | 155 | 9 | 532115 | P59596 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 26954467 |
| 737 | SARS-related coronavirus | SARS-related coronavirus | N | TKQYNVTQAF | 266 | 275 | 10 | 534068 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 26954467 |
| 738 | SARS-related coronavirus | SARS-related coronavirus | N | TKQYNVTQAF | 266 | 275 | 10 | 534068 | P59595 | HLA class I | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 26954467 |
| 739 | SARS-related coronavirus | SARS-related coronavirus | M | HLRMAGHSL | 147 | 155 | 9 | 532115 | P59596 | HLA class I | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 26954467 |
| 740 | Murine hepatitis virus strain JHM | Murine coronavirus | N | GPTKDVYEL | 342 | 350 | 9 | 21808 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 741 | Murine hepatitis virus strain JHM | Murine coronavirus | N | PTAGAFFF | 319 | 326 | 8 | 745623 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 742 | Murine hepatitis virus strain JHM | Murine coronavirus | N | TAGAFFF | 320 | 326 | 7 | 745653 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 743 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFF | 318 | 325 | 8 | 745560 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 744 | MERS-related coronavirus | MERS-related coronavirus | S | SFYAPEPITSL | 1190 | 1200 | 11 | 625112 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 745 | MERS-related coronavirus | MERS-related coronavirus | S | FYAPEPITSL | 1191 | 1200 | 10 | 616629 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 746 | MERS-related coronavirus | MERS-related coronavirus | S | FYAPEPITS | 1191 | 1199 | 9 | 616628 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 747 | MERS-related coronavirus | MERS-related coronavirus | S | SFYAPEPIT | 1190 | 1198 | 9 | 625111 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 748 | MERS-related coronavirus | MERS-related coronavirus | S | SFYAPEPI | 1190 | 1197 | 8 | 625110 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 749 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHSI | 292 | 300 | 9 | 628707 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 750 | MERS-related coronavirus | MERS-related coronavirus | S | KYYSIIPHSI | 291 | 300 | 10 | 620933 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 751 | MERS-related coronavirus | MERS-related coronavirus | S | KYYSIIPHS | 291 | 299 | 9 | 620932 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 752 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHS | 292 | 299 | 8 | 628706 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 753 | MERS-related coronavirus | MERS-related coronavirus | S | FAQSIFYRL | 972 | 980 | 9 | 616139 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 754 | MERS-related coronavirus | MERS-related coronavirus | S | FYRLNGVGI | 977 | 985 | 9 | 616635 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 755 | MERS-related coronavirus | MERS-related coronavirus | S | FYRLNGVGIT | 977 | 986 | 10 | 616636 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 756 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHSI | 292 | 300 | 9 | 628707 | 667489389 | H2-Kd | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus BALB/c | 27903740 |
| 757 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHSI | 292 | 300 | 9 | 628707 | 667489389 | H2-Kd | I | - | in vivo assay | protection from challenge | Mus musculus BALB/c | 27903740 |
| 758 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 28579232 |
| 759 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 28579232 |
| 760 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus BALB/c | 28579232 |
| 761 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IL-17 release | Mus musculus BALB/c | 28579232 |
| 762 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 28579232 |
| 763 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus BALB/c | 28579232 |
| 764 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IL-17 release | Mus musculus BALB/c | 28579232 |
| 765 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 28579232 |
| 766 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | QNIDAYKTFPKKEKK | 353 | 367 | 15 | 862950 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 767 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKEKKQKAP | 357 | 371 | 15 | 862444 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 768 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKEKK | 357 | 367 | 11 | 862443 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 769 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKEK | 357 | 366 | 10 | 862442 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 770 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKE | 357 | 365 | 9 | 862441 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 771 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | YKTFPKKEK | 358 | 366 | 9 | 863259 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 772 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | KTFPKKEKK | 359 | 367 | 9 | 862768 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 773 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKK | 357 | 364 | 8 | 862440 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 774 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | YKTFPKKE | 358 | 365 | 8 | 863258 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 775 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | KTFPKKEK | 359 | 366 | 8 | 862767 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 776 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | TFPKKEKK | 360 | 367 | 8 | 863104 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 777 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | YKTFPKKEKK | 358 | 367 | 10 | 863260 | 667489396 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 30558354 |
| 778 | SARS coronavirus Urbani | SARS-related coronavirus | N | PDDQIGYYRRATRRV | 81 | 95 | 15 | 47074 | P59595 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 16494977 |
| 779 | SARS-related coronavirus | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 780 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A2 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 15451471 |
| 781 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A2 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15451471 |
| 782 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 15016646 |
| 783 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 15016646 |
| 784 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 15016646 |
| 785 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | 51 chromium | cytotoxicity | Homo sapiens | 15016646 |
| 786 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | 51 chromium | cytotoxicity | Homo sapiens | 15016646 |
| 787 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 15016646 |
| 788 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15016646 |
| 789 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus HLA-A2.1/Kb Tg | 15016646 |
| 790 | SARS coronavirus Tor2 | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-Kb | I | Splenocyte | ICS | IFNg release | Mus musculus C57BL/6 | 15823604 |
| 791 | SARS coronavirus Tor2 | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | Splenocyte | ICS | IFNg release | Mus musculus C57BL/6 | 15823604 |
| 792 | SARS coronavirus Tor2 | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | Splenocyte | ICS | IFNg release | Mus musculus BALB/c | 15823604 |
| 793 | SARS coronavirus Tor2 | SARS-related coronavirus | S | TSTGNYNYKYRYLRH | 431 | 445 | 15 | 66460 | P59594 | - | - | Splenocyte | bioassay | IFNg release | Mus musculus BALB/c | 15823604 |
| 794 | SARS coronavirus Tor2 | SARS-related coronavirus | S | YNYKYRYLRHGKLRP | 436 | 450 | 15 | 75238 | P59594 | - | - | Splenocyte | bioassay | IFNg release | Mus musculus BALB/c | 15823604 |
| 795 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 796 | Human coronavirus 229E | Human coronavirus 229E | S | LLLNCLWSV | 77 | 85 | 9 | 37536 | P15423 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 797 | Human coronavirus 229E | Human coronavirus 229E | S | LITGRLAAL | 881 | 889 | 9 | 36723 | P15423 | HLA-A2 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15140958 |
| 798 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15972696 |
| 799 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 15972696 |
| 800 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | PBMC | ICS | IFNg release | Homo sapiens | 15972696 |
| 801 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | PBMC | ICS | IFNg release | Homo sapiens | 15972696 |
| 802 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 15972696 |
| 803 | SARS-related coronavirus | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 15972696 |
| 804 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15972696 |
| 805 | SARS-related coronavirus | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 15972696 |
| 806 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 14978121 |
| 807 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 14978121 |
| 808 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 12902505 |
| 809 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | - | - | - | in vivo assay | pathogen burden after challenge | Mus musculus C57BL/6 | 12902505 |
| 810 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | - | - | - | in vivo assay | pathogen burden after challenge | Mus musculus C57BL/6 | 12902505 |
| 811 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 12902505 |
| 812 | SARS coronavirus Urbani | SARS-related coronavirus | N | MSDNGPQSNQRSAPR | 1 | 15 | 15 | 42539 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 813 | SARS coronavirus Urbani | SARS-related coronavirus | N | PQSNQRSAPRITFGG | 6 | 20 | 15 | 49127 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 814 | SARS coronavirus Urbani | SARS-related coronavirus | N | RSAPRITFGGPTDST | 11 | 25 | 15 | 55800 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 815 | SARS coronavirus Urbani | SARS-related coronavirus | N | ITFGGPTDSTDNNQN | 16 | 30 | 15 | 28889 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 816 | SARS coronavirus Urbani | SARS-related coronavirus | N | PTDSTDNNQNGGRNG | 21 | 35 | 15 | 49606 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 817 | SARS coronavirus Urbani | SARS-related coronavirus | N | DNNQNGGRNGARPKQ | 26 | 40 | 15 | 9519 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 818 | SARS coronavirus Urbani | SARS-related coronavirus | N | ARPKQRRPQGLPNNT | 36 | 50 | 15 | 4213 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 819 | SARS coronavirus Urbani | SARS-related coronavirus | N | RRPQGLPNNTASWFT | 41 | 55 | 15 | 55683 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 820 | SARS coronavirus Urbani | SARS-related coronavirus | N | LPNNTASWFTALTQH | 46 | 60 | 15 | 38599 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 821 | SARS coronavirus Urbani | SARS-related coronavirus | N | ASWFTALTQHGKEEL | 51 | 65 | 15 | 4837 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 822 | SARS coronavirus Urbani | SARS-related coronavirus | N | ALTQHGKEELRFPRG | 56 | 70 | 15 | 2938 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 823 | SARS coronavirus Urbani | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 824 | SARS coronavirus Urbani | SARS-related coronavirus | N | ATRRVRGGDGKMKEL | 91 | 105 | 15 | 5133 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 825 | SARS coronavirus Urbani | SARS-related coronavirus | N | RGGDGKMKELSPRWY | 96 | 110 | 15 | 53873 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 826 | SARS coronavirus Urbani | SARS-related coronavirus | N | KMKELSPRWYFYYLG | 101 | 115 | 15 | 32340 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 827 | SARS coronavirus Urbani | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 828 | SARS coronavirus Urbani | SARS-related coronavirus | N | AQFAPSASAFFGMSR | 306 | 320 | 15 | 3957 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 829 | SARS coronavirus Urbani | SARS-related coronavirus | N | SASAFFGMSRIGMEV | 311 | 325 | 15 | 56980 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 830 | SARS coronavirus Urbani | SARS-related coronavirus | N | FGMSRIGMEVTPSGT | 316 | 330 | 15 | 16012 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 831 | SARS coronavirus Urbani | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 832 | SARS coronavirus Urbani | SARS-related coronavirus | N | KHIDAYKTFPPTEPK | 356 | 370 | 15 | 31115 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 833 | SARS coronavirus Urbani | SARS-related coronavirus | N | YKTFPPTEPKKDKKK | 361 | 375 | 15 | 74516 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 834 | SARS coronavirus Urbani | SARS-related coronavirus | N | PTEPKKDKKKKTDEA | 366 | 380 | 15 | 49619 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 835 | SARS coronavirus Urbani | SARS-related coronavirus | N | KDKKKKTDEAQPLPQ | 371 | 385 | 15 | 30185 | P59595 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 16494977 |
| 836 | SARS coronavirus Urbani | SARS-related coronavirus | N | GAIKLDDKDPQFKDN | 336 | 350 | 15 | 18622 | P59595 | - | - | PBMC | ELISA | IFNg release | Macaca cyclopis | 16494977 |
| 837 | SARS coronavirus Urbani | SARS-related coronavirus | N | PDDQIGYYRRATRRV | 81 | 95 | 15 | 47074 | P59595 | H2-d class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB/c | 16494977 |
| 838 | SARS-related coronavirus | SARS-related coronavirus | N | NTNSGPDDQIGYYRRATR | 76 | 93 | 18 | 46198 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 839 | SARS-related coronavirus | SARS-related coronavirus | N | GPDDQIGYYRRATRRVRGGD | 80 | 99 | 20 | 21585 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 840 | SARS-related coronavirus | SARS-related coronavirus | N | GPDDQIGYYRRATRRVRGGD | 80 | 99 | 20 | 21585 | P59595 | H2-d class I | I | Splenocyte | in vitro assay | cytotoxicity | Mus musculus BALB/c | 16387339 |
| 841 | SARS-related coronavirus | SARS-related coronavirus | N | QIGYYRRATRRVRGGDGK | 84 | 101 | 18 | 51074 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 842 | SARS-related coronavirus | SARS-related coronavirus | N | TRRVRGGDGKMKELSPRW | 92 | 109 | 18 | 66094 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 843 | SARS-related coronavirus | SARS-related coronavirus | N | GKMKELSPRWYFYYL | 100 | 114 | 15 | 20633 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 844 | SARS-related coronavirus | SARS-related coronavirus | N | GIVWVATEGALNTPKDHIGT | 130 | 149 | 20 | 20485 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 845 | SARS-related coronavirus | SARS-related coronavirus | N | GIVWVATEGALNTPKDHIGT | 130 | 149 | 20 | 20485 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 16387339 |
| 846 | SARS-related coronavirus | SARS-related coronavirus | N | QQQGQTVTKKSAAEASKK | 241 | 258 | 18 | 52117 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 847 | SARS-related coronavirus | SARS-related coronavirus | N | ILLNKHIDAYKTFPP | 352 | 366 | 15 | 27183 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 848 | SARS-related coronavirus | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 16387339 |
| 849 | SARS-related coronavirus | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | H2-d class I | I | Splenocyte | in vitro assay | cytotoxicity | Mus musculus BALB/c | 16387339 |
| 850 | SARS-related coronavirus | SARS-related coronavirus | N | TWLTYHGAIKLDDKDPQF | 330 | 347 | 18 | 67276 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 851 | SARS-related coronavirus | SARS-related coronavirus | N | IKLDDKDPQFKDNVILL | 338 | 354 | 17 | 26838 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 852 | SARS-related coronavirus | SARS-related coronavirus | N | PQFKDNVILLNKHIDAYK | 345 | 362 | 18 | 48995 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 853 | SARS-related coronavirus | SARS-related coronavirus | N | IRQGTDYKHWPQIAQFA | 293 | 309 | 17 | 28371 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 854 | SARS-related coronavirus | SARS-related coronavirus | N | KHWPQIAQFAPSASAFF | 300 | 316 | 17 | 31166 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 855 | SARS-related coronavirus | SARS-related coronavirus | N | AQFAPSASAFFGMSRIGM | 306 | 323 | 18 | 3958 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 856 | SARS-related coronavirus | SARS-related coronavirus | N | AFFGMSRIGMEVTPSGTW | 314 | 331 | 18 | 1295 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 857 | SARS-related coronavirus | SARS-related coronavirus | N | GMEVTPSGTWLTYHGAIK | 322 | 339 | 18 | 21264 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 858 | SARS-related coronavirus | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 859 | SARS-related coronavirus | SARS-related coronavirus | N | YKTFPPTEPKKDKKKK | 361 | 376 | 16 | 74517 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 16690096 |
| 860 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7815531 |
| 861 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 862 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 863 | Murine hepatitis virus strain JHM | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | H2-b class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 864 | Murine hepatitis virus strain JHM | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | H2-b class II | II | T cell CD4+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 865 | Murine hepatitis virus strain JHM | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | T cell CD4+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 866 | Murine hepatitis virus strain JHM | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 867 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 16816374 |
| 868 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | TNF release | Mus musculus C57BL/6 | 16816374 |
| 869 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 16816374 |
| 870 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 16816374 |
| 871 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 16887973 |
| 872 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 16887973 |
| 873 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 874 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 875 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 876 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 877 | SARS coronavirus BJ01 | SARS-related coronavirus | S | KLPDDFMGCV | 411 | 420 | 10 | 32069 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 878 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 879 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 880 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 881 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 882 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 883 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 884 | SARS-related coronavirus | SARS-related coronavirus | S | ILPDPLKPT | 787 | 795 | 9 | 27241 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 885 | SARS-related coronavirus | SARS-related coronavirus | S | VVFLHVTYV | 1042 | 1050 | 9 | 71663 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A2 Tg | 16630549 |
| 886 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 887 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 888 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 889 | SARS-related coronavirus | SARS-related coronavirus | S | ILPDPLKPT | 787 | 795 | 9 | 27241 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 890 | SARS-related coronavirus | SARS-related coronavirus | S | VVFLHVTYV | 1042 | 1050 | 9 | 71663 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 891 | SARS-related coronavirus | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 892 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 16630549 |
| 893 | SARS coronavirus Urbani | SARS-related coronavirus | N | MASGGGETALALLLLDRLNQLESKV | 211 | 235 | 25 | 41122 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 17183651 |
| 894 | SARS coronavirus Urbani | SARS-related coronavirus | N | TWLTYHGAIKLDDKDPQFKDNVILL | 330 | 354 | 25 | 67277 | P59595 | - | - | PBMC | ELISPOT | IFNg release | Homo sapiens | 17183651 |
| 895 | SARS-related coronavirus | SARS-related coronavirus | N | PTDSTDNNQNGGRNG | 21 | 35 | 15 | 49606 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 896 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 897 | SARS-related coronavirus | SARS-related coronavirus | N | PTDSTDNNQNGGRNG | 21 | 35 | 15 | 49606 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 898 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 899 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus C57BL/6 | 17392374 |
| 900 | SARS-related coronavirus | SARS-related coronavirus | N | FYYLGTGPEASLPYG | 111 | 125 | 15 | 18487 | P59595 | H2-b class II | II | - | biological activity | antibody help | Mus musculus C57BL/6 | 17392374 |
| 901 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 902 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus C3H | 17392374 |
| 903 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | T cell | 3H-thymidine | proliferation | Mus musculus BALB/c | 17392374 |
| 904 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | - | biological activity | antibody help | Mus musculus C3H | 17392374 |
| 905 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 906 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus BALB/c | 17392374 |
| 907 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | - | biological activity | antibody help | Mus musculus BALB/c | 17392374 |
| 908 | SARS-related coronavirus | SARS-related coronavirus | N | VILLNKHIDAYKTFP | 351 | 365 | 15 | 69035 | P59595 | H2-d class II | II | T cell | 3H-thymidine | proliferation | Mus musculus BALB/c | 17392374 |
| 909 | SARS-related coronavirus | SARS-related coronavirus | N | RSAPRITFGGPTDST | 11 | 25 | 15 | 55800 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 910 | SARS-related coronavirus | SARS-related coronavirus | N | ASWFTALTQHGKEEL | 51 | 65 | 15 | 4837 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 911 | SARS-related coronavirus | SARS-related coronavirus | N | GKEELRFPRGQGVPI | 61 | 75 | 15 | 20544 | P59595 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 17392374 |
| 912 | SARS-related coronavirus | SARS-related coronavirus | N | PDDQIGYYRRATRRV | 81 | 95 | 15 | 47074 | P59595 | H2-d class II | II | T cell | 3H-thymidine | proliferation | Mus musculus BALB/c | 17392374 |
| 913 | SARS-related coronavirus | SARS-related coronavirus | N | WLTYHGAIKLDDKDP | 331 | 345 | 15 | 72815 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 914 | SARS-related coronavirus | SARS-related coronavirus | N | WLTYHGAIKLDDKDP | 331 | 345 | 15 | 72815 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 915 | SARS-related coronavirus | SARS-related coronavirus | N | ATRRVRGGDGKMKEL | 91 | 105 | 15 | 5133 | P59595 | H2-k class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C3H | 17392374 |
| 916 | SARS-related coronavirus | SARS-related coronavirus | N | ALNTPKDHI | 139 | 147 | 9 | 2802 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 917 | SARS-related coronavirus | SARS-related coronavirus | N | LQLPQGTTL | 160 | 168 | 9 | 38881 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 918 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 919 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 920 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 921 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 922 | SARS-related coronavirus | SARS-related coronavirus | N | ILLNKHIDA | 352 | 360 | 9 | 27182 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 17629360 |
| 923 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 17629360 |
| 924 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 17629360 |
| 925 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 17629360 |
| 926 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2 class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus | 9621053 |
| 927 | SARS-related coronavirus | SARS-related coronavirus | S | GNYNYKYRYLRHGKL | 434 | 448 | 15 | 21552 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB/c | 17506989 |
| 928 | SARS coronavirus BJ01 | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 929 | SARS coronavirus BJ01 | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 930 | SARS coronavirus BJ01 | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 931 | SARS coronavirus BJ01 | SARS-related coronavirus | S | LITGRLQSL | 978 | 986 | 9 | 36724 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 932 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 933 | SARS coronavirus BJ01 | SARS-related coronavirus | S | RLNEVAKNL | 1167 | 1175 | 9 | 54680 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 HLA-A*0201/Kb Tg | 16887973 |
| 934 | SARS coronavirus Urbani | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 17709158 |
| 935 | SARS coronavirus Urbani | SARS-related coronavirus | S | ERNFTTAPAICHEGKAYF | 1054 | 1071 | 18 | 79810 | P59594 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 17709158 |
| 936 | SARS coronavirus Urbani | SARS-related coronavirus | S | FVSGNCDVVIGIINNTVY | 1103 | 1120 | 18 | 79833 | P59594 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 17709158 |
| 937 | SARS coronavirus Urbani | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB/c | 17709158 |
| 938 | SARS coronavirus Urbani | SARS-related coronavirus | S | LMSFPQAAPHGVVFLHV | 1031 | 1047 | 17 | 38118 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 17709158 |
| 939 | SARS coronavirus Urbani | SARS-related coronavirus | S | VIGIINNTVYDPLQPEL | 1111 | 1127 | 17 | 68971 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 940 | SARS coronavirus Urbani | SARS-related coronavirus | S | VIGIINNTVYDPLQPEL | 1111 | 1127 | 17 | 68971 | P59594 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 17709158 |
| 941 | SARS coronavirus Urbani | SARS-related coronavirus | S | LMSFPQAAPHGVVFLHV | 1031 | 1047 | 17 | 38118 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 942 | SARS coronavirus Urbani | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 17709158 |
| 943 | SARS coronavirus Urbani | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 944 | SARS coronavirus Urbani | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-d class II | II | T cell CD4+ | ICS | IL-2 release | Mus musculus BALB/c | 17709158 |
| 945 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 946 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 7494335 |
| 947 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2-Kb | I | T cell | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 7494335 |
| 948 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | Splenocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 7494335 |
| 949 | Murine hepatitis virus | Murine coronavirus | S | CSRWNGPHL | 0 | 0 | 9 | 7082 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 950 | Murine hepatitis virus | Murine coronavirus | S | CSLWSGPHL | 0 | 0 | 9 | 7034 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 951 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGLHL | 0 | 0 | 9 | 7031 | P11224 | H2-Db | I | Lymphocyte | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8808680 |
| 952 | SARS-related coronavirus | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | - | - | T cell | ELISPOT | IFNg release | Mus musculus BALB/c | 18289745 |
| 953 | SARS-related coronavirus | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | H2-d class II | II | T cell | ELISPOT | IL-4 release | Mus musculus BALB/c | 18289745 |
| 954 | SARS-related coronavirus | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-d class II | II | T cell | ELISPOT | IL-2 release | Mus musculus BALB/c | 18289745 |
| 955 | SARS-related coronavirus | SARS-related coronavirus | S | NYNYKYRYLR | 435 | 444 | 10 | 46680 | P59594 | - | - | T cell | ELISPOT | IL-10 release | Mus musculus BALB/c | 18289745 |
| 956 | SARS-related coronavirus | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | - | - | T cell | ELISPOT | IFNg release | Mus musculus BALB/c | 18289745 |
| 957 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB.B | 17913802 |
| 958 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus BALB.B | 17913802 |
| 959 | Murine hepatitis virus strain JHM | Murine coronavirus | M | VYVRPIIEDYHTLT | 134 | 147 | 14 | 72188 | P03415 | H2-b class II | II | T cell CD4+ | ICS | IFNg release | Mus musculus BALB.B | 17913802 |
| 960 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | Mononuclear cell | 51 chromium | cytotoxicity | Mus musculus BALB.B | 17913802 |
| 961 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | biological activity | degranulation | Mus musculus BALB.B | 17913802 |
| 962 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7558143 |
| 963 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 964 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 965 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7558143 |
| 966 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 967 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7558143 |
| 968 | Murine hepatitis virus strain A59 | Murine coronavirus | S | IEEWLTAR | 331 | 338 | 8 | 25799 | P11224 | H2-d class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus BALB/c | 7558143 |
| 969 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7558143 |
| 970 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 971 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7558143 |
| 972 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 973 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7558143 |
| 974 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 975 | Murine hepatitis virus strain A59 | Murine coronavirus | S | EWLTARSVP | 333 | 341 | 9 | 14943 | P11224 | H2-b class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus C57BL/6 | 7558143 |
| 976 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 10570300 |
| 977 | SARS-related coronavirus | SARS-related coronavirus | S | TECANLLLQYGSFCTQL | 729 | 745 | 17 | 63309 | P59594 | HLA-DR8 | II | T cell CD4+ | 51 chromium | cytotoxicity | Homo sapiens | 17692881 |
| 978 | SARS-related coronavirus | SARS-related coronavirus | S | TECANLLLQYGSFCTQL | 729 | 745 | 17 | 63309 | P59594 | HLA-DR8 | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 17692881 |
| 979 | SARS-related coronavirus | SARS-related coronavirus | S | TECANLLLQYGSFCTQL | 729 | 745 | 17 | 63309 | P59594 | HLA-DR8 | II | T cell CD4+ | ELISPOT | IFNg release | Homo sapiens | 17692881 |
| 980 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DR8 | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 17692881 |
| 981 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DR8 | II | T cell CD4+ | 51 chromium | cytotoxicity | Homo sapiens | 17692881 |
| 982 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DR8 | II | T cell CD4+ | ELISPOT | IFNg release | Homo sapiens | 17692881 |
| 983 | SARS-related coronavirus | SARS-related coronavirus | S | NIDATSTGNYNYKYRYLR | 427 | 444 | 18 | 44199 | P59594 | HLA class II | II | T cell CD4+ | 51 chromium | cytotoxicity | Homo sapiens | 17692881 |
| 984 | SARS-related coronavirus | SARS-related coronavirus | S | NIDATSTGNYNYKYRYLR | 427 | 444 | 18 | 44199 | P59594 | HLA class II | II | T cell CD4+ | ELISPOT | IFNg release | Homo sapiens | 17692881 |
| 985 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 15994805 |
| 986 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 598 | 605 | 8 | 53307 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 15994805 |
| 987 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | KAVSAAGVHFKAGGPI | 186 | 201 | 16 | 29985 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 988 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | ITYKVMREVRALAYFVNGTA | 201 | 220 | 20 | 29165 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 989 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | QYNTGNFSDGLYPFTN | 237 | 252 | 16 | 53015 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 990 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | PPNSGGVNTIQLYQTKTAQ | 286 | 304 | 19 | 48846 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 991 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | GSQAIENQFYIKLTNGS | 521 | 537 | 17 | 22456 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 992 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | S | NCPYVSYGKFCIKPDGSIST | 8 | 27 | 20 | 43383 | P11223 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 993 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | N | GYWRRQARYKPGKSG | 69 | 83 | 15 | 23501 | P69596 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 994 | Avian infectious bronchitis virus (strain Vic S) | Avian coronavirus | N | PAADLNWGENQDGIVWV | 100 | 116 | 17 | 46737 | P69596 | chicken class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Gallus gallus White Leghorn | 15868095 |
| 995 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 996 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAF | 318 | 324 | 7 | 3836 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 997 | Murine hepatitis virus strain JHM | Murine coronavirus | N | TPEDRSLLA | 429 | 437 | 9 | 65539 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 998 | Murine hepatitis virus strain JHM | Murine coronavirus | N | KILNKPRQKRTPNK | 266 | 279 | 14 | 31329 | P03416 | H2-IEd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 8918920 |
| 999 | Murine hepatitis virus strain JHM | Murine coronavirus | N | KILNKPRQKRTPNK | 266 | 279 | 14 | 31329 | P03416 | H2-IEd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 8918920 |
| 1000 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 8627236 |
| 1001 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18322201 |
| 1002 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18322201 |
| 1003 | Murine hepatitis virus strain JHM | Murine coronavirus | M | IDMKGTVYVRPIIE | 128 | 141 | 14 | 77913 | P03415 | H2-IAb | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 11831697 |
| 1004 | Murine hepatitis virus strain JHM | Murine coronavirus | M | VYVRPIIEDYHTLT | 134 | 147 | 14 | 72188 | P03415 | H2-IAb | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 11831697 |
| 1005 | Murine hepatitis virus strain JHM | Murine coronavirus | M | YVRPIIEDYHTLTA | 135 | 148 | 14 | 78085 | P03415 | H2-IAb | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 11831697 |
| 1006 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 9782354 |
| 1007 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 9782354 |
| 1008 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | Splenocyte | 51 chromium | cytotoxicity | Mus musculus BALB/c | 10201909 |
| 1009 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 10201909 |
| 1010 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 10201909 |
| 1011 | Murine hepatitis virus strain 4 | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 1012 | Murine hepatitis virus strain 4 | Murine coronavirus | S | EWLTAKSVPSPLNWE | 333 | 347 | 15 | 14942 | P11224 | - | - | T cell | ELISPOT | IFNg release | Mus musculus C57BL/6 | 9375010 |
| 1013 | Murine hepatitis virus strain 4 | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 1014 | Murine hepatitis virus strain 4 | Murine coronavirus | S | DCKIEEWLTAKSVPS | 328 | 342 | 15 | 78948 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 1015 | Murine hepatitis virus strain 4 | Murine coronavirus | S | RYVQAESLSCNNIDA | 363 | 377 | 15 | 79077 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 1016 | Murine hepatitis virus strain 4 | Murine coronavirus | S | SGFLQTANYKIDTAA | 408 | 422 | 15 | 79080 | P11224 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 1017 | Murine hepatitis virus strain 4 | Murine coronavirus | S | LSSLLRYVQAESLSC | 358 | 372 | 15 | 39670 | P11224 | H2-b class II | II | T cell CD4+ | ELISPOT | IFNg release | Mus musculus C57BL/6 | 9375010 |
| 1018 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-b class II | II | T cell CD4+ | ELISPOT | IFNg release | Mus musculus C57BL/6 | 9375010 |
| 1019 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-b class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 9375010 |
| 1020 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 1021 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 1022 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7790024 |
| 1023 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7790024 |
| 1024 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | T cell | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 1025 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | PBMC | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 1026 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | PBMC | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 1027 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | PBMC | 3H-thymidine | proliferation | Sus scrofa | 7571447 |
| 1028 | Transmissible gastroenteritis virus MAD88 | Alphacoronavirus 1 | N | QFLQQINAYARPSEV | 321 | 335 | 15 | 87544 | P25909 | SLA class II | II | T cell | biological activity | antibody help | Sus scrofa | 7571447 |
| 1029 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFK | 71 | 78 | 8 | 94968 | P69596 | H2-IEd | II | T cell CD4+ | bioassay | IL-2 release | Mus musculus | 1718856 |
| 1030 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFK | 71 | 78 | 8 | 94968 | P69596 | H2-IEd | II | T cell CD4+ | bioassay | IL-2 release | Mus musculus | 1718856 |
| 1031 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | QHGYWRRQARFKPGKGG | 67 | 83 | 17 | 94903 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 1032 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | QHGYWRRQARFKPGKGG | 67 | 83 | 17 | 94903 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 1033 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | QHGYWRRQARFKPGKGG | 67 | 83 | 17 | 94903 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 1034 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFKPGKGG | 71 | 83 | 13 | 94969 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 1035 | Avian infectious bronchitis virus (strain M41) | Avian coronavirus | N | WRRQARFKPGKGG | 71 | 83 | 13 | 94969 | P69596 | chicken class II | II | T cell | 3H-thymidine | proliferation | Gallus gallus White Leghorn | 1718856 |
| 1036 | Murine hepatitis virus strain JHM | Murine coronavirus | N | GLAPTAGAFFFGSKL | 0 | 0 | 15 | 96324 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 1037 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 1038 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 1039 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 1040 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 1041 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 1042 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-d class I | I | T cell | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7693965 |
| 1043 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 1044 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 1045 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 1046 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 1047 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 7790024 |
| 1048 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1049 | Murine hepatitis virus | Murine coronavirus | S | CSLWSGPHL | 0 | 0 | 9 | 7034 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1050 | Murine hepatitis virus | Murine coronavirus | S | CFLWNGPHL | 0 | 0 | 9 | 98709 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1051 | Murine hepatitis virus | Murine coronavirus | S | CPLWNGPHL | 0 | 0 | 9 | 98712 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1052 | Murine hepatitis virus | Murine coronavirus | S | CSFWNGPHL | 0 | 0 | 9 | 98714 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1053 | Murine hepatitis virus | Murine coronavirus | S | CSPWNGPHL | 0 | 0 | 9 | 98720 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1054 | Murine hepatitis virus | Murine coronavirus | S | CSLWHGPHL | 0 | 0 | 9 | 98716 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1055 | Murine hepatitis virus | Murine coronavirus | S | CSLWDGPHL | 0 | 0 | 9 | 98715 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1056 | Murine hepatitis virus | Murine coronavirus | S | CSLWTGPHL | 0 | 0 | 9 | 98719 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1057 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGHHL | 0 | 0 | 9 | 98717 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1058 | Murine hepatitis virus | Murine coronavirus | S | ECSWNGPHL | 0 | 0 | 9 | 98745 | P11224 | H2-b class I | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 10049826 |
| 1059 | SARS-related coronavirus | SARS-related coronavirus | S | VRGWVFGSTMNNKSQSVI | 98 | 115 | 18 | 100627 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1060 | SARS-related coronavirus | SARS-related coronavirus | S | CTFEYISDAFSLD | 159 | 171 | 13 | 99918 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1061 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1062 | SARS-related coronavirus | SARS-related coronavirus | S | TNFRAILTAFSPAQDIW | 229 | 245 | 17 | 100567 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1063 | SARS-related coronavirus | SARS-related coronavirus | S | CSQNPLAELKCSVKSFEI | 278 | 295 | 18 | 7065 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1064 | SARS-related coronavirus | SARS-related coronavirus | S | KSFEIDKGIYQTSNFRVV | 291 | 308 | 18 | 33305 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1065 | SARS-related coronavirus | SARS-related coronavirus | S | KKISNCVADYSVLYNSTF | 343 | 360 | 18 | 31582 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1066 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1067 | SARS-related coronavirus | SARS-related coronavirus | S | KSIVAYTMSLGADSSIAY | 672 | 689 | 18 | 100230 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1068 | SARS-related coronavirus | SARS-related coronavirus | S | VKQMYKTPTLKYFGGFNF | 767 | 784 | 18 | 100612 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1069 | SARS-related coronavirus | SARS-related coronavirus | S | GFMKQYGECLGDINARDL | 814 | 831 | 18 | 100057 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1070 | SARS-related coronavirus | SARS-related coronavirus | S | MAYRFNGIGVTQNVLY | 884 | 899 | 16 | 100300 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1071 | SARS-related coronavirus | SARS-related coronavirus | S | ESLTTTSTALGKLQDVV | 918 | 934 | 17 | 14208 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1072 | SARS-related coronavirus | SARS-related coronavirus | S | QALNTLVKQLSSNFGAI | 939 | 955 | 17 | 50311 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1073 | SARS-related coronavirus | SARS-related coronavirus | S | QLIRAAEIRASANLAATK | 993 | 1010 | 18 | 100428 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1074 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1075 | SARS-related coronavirus | SARS-related coronavirus | S | EIFRSDTLYLTQDLFLPF | 45 | 62 | 18 | 99995 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1076 | SARS-related coronavirus | SARS-related coronavirus | S | YLTQDLFLPFYSNVTGFH | 53 | 70 | 18 | 100665 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1077 | SARS-related coronavirus | SARS-related coronavirus | S | TGFHTINHTFGNPVIPFK | 67 | 84 | 18 | 100553 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1078 | SARS-related coronavirus | SARS-related coronavirus | S | TLKPIFKLPLGINITNFR | 215 | 232 | 18 | 100561 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1079 | SARS-related coronavirus | SARS-related coronavirus | S | TAFSPAQDIWGTSAAAYF | 236 | 253 | 18 | 100541 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1080 | SARS-related coronavirus | SARS-related coronavirus | S | KSFEIDKGIYQTSNFRVV | 291 | 308 | 18 | 33305 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1081 | SARS-related coronavirus | SARS-related coronavirus | S | IYQTSNFRVVPSGDVVRF | 299 | 316 | 18 | 29666 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1082 | SARS-related coronavirus | SARS-related coronavirus | S | STFFSTFKCYGVSATKL | 358 | 374 | 17 | 61598 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1083 | SARS-related coronavirus | SARS-related coronavirus | S | LLRSTSQKSIVAYTMSL | 665 | 681 | 17 | 37758 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1084 | SARS-related coronavirus | SARS-related coronavirus | S | KSIVAYTMSLGADSSIAY | 672 | 689 | 18 | 100230 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1085 | SARS-related coronavirus | SARS-related coronavirus | S | AQKFNGLTVLPPLLTDDM | 834 | 851 | 18 | 99899 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1086 | SARS-related coronavirus | SARS-related coronavirus | S | GAALQIPFAMQMAYRF | 873 | 888 | 16 | 100048 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1087 | SARS-related coronavirus | SARS-related coronavirus | S | CTFEYISDAFSLD | 159 | 171 | 13 | 99918 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1088 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1089 | SARS-related coronavirus | SARS-related coronavirus | S | KSFEIDKGIYQTSNFRVV | 291 | 308 | 18 | 33305 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1090 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1091 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1092 | SARS-related coronavirus | SARS-related coronavirus | S | CTFEYISDAFSLD | 159 | 171 | 13 | 99918 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 1093 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 1094 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 1095 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 1096 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IFNg release | Homo sapiens | 19050106 |
| 1097 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IFNg release | Homo sapiens | 19050106 |
| 1098 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IFNg release | Homo sapiens | 19050106 |
| 1099 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-13 release | Homo sapiens | 19050106 |
| 1100 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-13 release | Homo sapiens | 19050106 |
| 1101 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-10 release | Homo sapiens | 19050106 |
| 1102 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-10 release | Homo sapiens | 19050106 |
| 1103 | SARS-related coronavirus | SARS-related coronavirus | S | RPFERDISNVPFS | 449 | 461 | 13 | 100481 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-5 release | Homo sapiens | 19050106 |
| 1104 | SARS-related coronavirus | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-5 release | Homo sapiens | 19050106 |
| 1105 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-13 release | Homo sapiens | 19050106 |
| 1106 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-10 release | Homo sapiens | 19050106 |
| 1107 | SARS-related coronavirus | SARS-related coronavirus | S | DAFSLDVSEKSGN | 166 | 178 | 13 | 99926 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | ELISA | IL-5 release | Homo sapiens | 19050106 |
| 1108 | SARS coronavirus Tor2 | SARS-related coronavirus | ORF 3a | PLQASLPFGWLVIGV | 36 | 50 | 15 | 101126 | P59632 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1109 | SARS coronavirus Tor2 | SARS-related coronavirus | S | NYNYKYRYLRHGKLRPF | 435 | 451 | 17 | 46681 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1110 | SARS coronavirus Tor2 | SARS-related coronavirus | S | AGCLIGAEHVDTSYECDI | 633 | 650 | 18 | 100711 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1111 | SARS coronavirus Tor2 | SARS-related coronavirus | N | GETALALLLLDRLNQ | 216 | 230 | 15 | 19443 | P59595 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1112 | SARS coronavirus Tor2 | SARS-related coronavirus | M | GHLRMAGHSLGRCDI | 146 | 160 | 15 | 100879 | P59596 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1113 | SARS coronavirus Tor2 | SARS-related coronavirus | S | NFNGLTGTGVLTPSSKRF | 528 | 545 | 18 | 43894 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1114 | SARS coronavirus Tor2 | SARS-related coronavirus | S | DIPIGAGICASYHTVSLL | 649 | 666 | 18 | 100778 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1115 | SARS coronavirus Tor2 | SARS-related coronavirus | S | SWFITQRNFFSPQII | 1083 | 1097 | 15 | 100537 | P59594 | - | - | T cell | ELISPOT | IFNg release | Homo sapiens | 18832706 |
| 1116 | SARS-related coronavirus | SARS-related coronavirus | S | YLRHGKLRPFERDISNVP | 442 | 459 | 18 | 100664 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1117 | SARS-related coronavirus | SARS-related coronavirus | S | YLRHGKLRPFERDISNVP | 442 | 459 | 18 | 100664 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1118 | SARS-related coronavirus | SARS-related coronavirus | S | YLRHGKLRPFERDISNVP | 442 | 459 | 18 | 100664 | P59594 | HLA-DRB1*04:01 | II | Lymphocyte | 3H-thymidine | proliferation | Mus musculus HLA-DR4/IE Tg H2-II null | 19050106 |
| 1119 | SARS-related coronavirus | SARS-related coronavirus | S | NAFNCTFEYISDAFSLDV | 155 | 172 | 18 | 100316 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1120 | SARS-related coronavirus | SARS-related coronavirus | S | NPFFAVSKPMGTQTHTMI | 135 | 152 | 18 | 100347 | P59594 | HLA-DRA*01:01/DRB1*0 | II | T cell CD4+ | multimer/tetramer | qualitative binding | Homo sapiens | 19050106 |
| 1121 | SARS-related coronavirus | SARS-related coronavirus | S | QLIRAAEIRASANLAATK | 993 | 1010 | 18 | 100428 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 1122 | SARS-related coronavirus | SARS-related coronavirus | S | VRGWVFGSTMNNKSQSVI | 98 | 115 | 18 | 100627 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 1123 | SARS-related coronavirus | SARS-related coronavirus | S | TNFRAILTAFSPAQDIW | 229 | 245 | 17 | 100567 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 1124 | SARS-related coronavirus | SARS-related coronavirus | S | ESLTTTSTALGKLQDVV | 918 | 934 | 17 | 14208 | P59594 | HLA-DRB1*04:01 | II | T cell CD4+ | 3H-thymidine | proliferation | Homo sapiens | 19050106 |
| 1125 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-IAd | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus BALB/c | 7790024 |
| 1126 | Murine hepatitis virus strain A59 | Murine coronavirus | S | ACNIEEWLTARSVPS | 328 | 342 | 15 | 102285 | P11224 | H2-b class II | II | T cell | 3H-thymidine | proliferation | Mus musculus C57BL/6 | 7790024 |
| 1127 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1128 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1129 | SARS coronavirus Urbani | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1130 | SARS coronavirus Urbani | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1131 | SARS coronavirus Urbani | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1132 | SARS coronavirus Urbani | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1133 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1134 | SARS coronavirus Urbani | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1135 | SARS coronavirus Urbani | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1136 | SARS coronavirus Urbani | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | - | in vivo assay | pathogen burden after challenge | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19490987 |
| 1137 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | IFNg release | Homo sapiens | 12692247 |
| 1138 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | GM-CSF release | Homo sapiens | 12692247 |
| 1139 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | GM-CSF release | Homo sapiens | 12692247 |
| 1140 | Human coronavirus OC43 | Betacoronavirus 1 | NSP 2a | TMLDIQPED | 52 | 60 | 9 | 112359 | Q80872 | HLA-A2 | I | T cell CD8+ | ELISA | GM-CSF release | Homo sapiens | 12692247 |
| 1141 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 1142 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 1143 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 1144 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 1145 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 1146 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus C57BL/6 X BALB/c | 10477608 |
| 1147 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | - | - | Splenocyte | cytometric bead array | IFNg release | Mus musculus SJL | 17376542 |
| 1148 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | - | - | Splenocyte | cytometric bead array | IFNg release | Mus musculus SJL | 17376542 |
| 1149 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 1150 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 1151 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 1152 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 1153 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 1154 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | H2-s class II | II | Splenocyte | 3H-thymidine | proliferation | Mus musculus SJL | 17376542 |
| 1155 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3767 | 3778 | 12 | 34033 | P0C6X9 | - | - | Splenocyte | cytometric bead array | IFNg release | Mus musculus SJL | 17376542 |
| 1156 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | 3H-thymidine | proliferation | Mus musculus SJL | 9759846 |
| 1157 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | 3H-thymidine | proliferation | Mus musculus SJL | 9759846 |
| 1158 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IFNg release | Mus musculus SJL | 9759846 |
| 1159 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IL-2 release | Mus musculus SJL | 9759846 |
| 1160 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IFNg release | Mus musculus SJL | 9759846 |
| 1161 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | T cell | ELISA | IL-2 release | Mus musculus SJL | 9759846 |
| 1162 | Murine hepatitis virus | Murine coronavirus | ORF 1a | KVIAKWLAVNVL | 186 | 197 | 12 | 34033 | P0C6V0 | H2-IAs | II | - | in vivo assay | disease exacerbation | Mus musculus SJL | 9759846 |
| 1163 | SARS-related coronavirus | SARS-related coronavirus | S | ALNTLVKQL | 940 | 948 | 9 | 2801 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 1164 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 1165 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 1166 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 19958537 |
| 1167 | SARS-related coronavirus | SARS-related coronavirus | S | ALNTLVKQL | 940 | 948 | 9 | 2801 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 1168 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 1169 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 1170 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Homo sapiens | 19958537 |
| 1171 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 1172 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 1173 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 1174 | SARS-related coronavirus | SARS-related coronavirus | S | NLNESLIDL | 1174 | 1182 | 9 | 44814 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 1175 | SARS-related coronavirus | SARS-related coronavirus | S | SIVAYTMSL | 673 | 681 | 9 | 58730 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 1176 | SARS-related coronavirus | SARS-related coronavirus | S | VLNDILSRL | 958 | 966 | 9 | 69657 | P59594 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A2.1/Kb Tg | 19958537 |
| 1177 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | CLDAGINYV | 2187 | 2195 | 9 | 6543 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1178 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | AMWLLLLSI | 2207 | 2215 | 9 | 3212 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1179 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | WLMWFIISI | 2340 | 2348 | 9 | 72761 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1180 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ILLLDQVLV | 2546 | 2554 | 9 | 27170 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1181 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | LLCVLAALV | 2755 | 2763 | 9 | 120069 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1182 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ALSGVFCGV | 2990 | 2998 | 9 | 2880 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1183 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | VLAWLYAAV | 3444 | 3452 | 9 | 69392 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1184 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | TLMNVITLV | 3687 | 3695 | 9 | 64955 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1185 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | SMWALVISV | 3709 | 3717 | 9 | 59776 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1186 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | H2 class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1187 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | CLDAGINYV | 2187 | 2195 | 9 | 6543 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1188 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | WLMWFIISI | 2340 | 2348 | 9 | 72761 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1189 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ILLLDQVLV | 2546 | 2554 | 9 | 27170 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1190 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | LLCVLAALV | 2755 | 2763 | 9 | 120069 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1191 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ALSGVFCGV | 2990 | 2998 | 9 | 2880 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1192 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | TLMNVITLV | 3687 | 3695 | 9 | 64955 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1193 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | SMWALVISV | 3709 | 3717 | 9 | 59776 | P0C6U8 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1194 | SARS-related coronavirus | SARS-related coronavirus | S | FIAGLIAIV | 1202 | 1210 | 9 | 16156 | P59594 | HLA-A*02:01 | I | - | in vivo assay | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1195 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | CLDAGINYV | 2187 | 2195 | 9 | 6543 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1196 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | WLMWFIISI | 2340 | 2348 | 9 | 72761 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1197 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ILLLDQVLV | 2546 | 2554 | 9 | 27170 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1198 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | LLCVLAALV | 2755 | 2763 | 9 | 120069 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1199 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | ALSGVFCGV | 2990 | 2998 | 9 | 2880 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1200 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | TLMNVITLV | 3687 | 3695 | 9 | 64955 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1201 | SARS coronavirus Urbani | SARS-related coronavirus | ORF 1a | SMWALVISV | 3709 | 3717 | 9 | 59776 | P0C6U8 | HLA-A*02:01 | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus HLA-A*0201/Db-human b2m Tg (HHD) | 19748524 |
| 1202 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RFPRGQGVPINTNSGPDDQI | 66 | 85 | 20 | 53758 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1203 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NTNSGPDDQIGYYRRATR | 76 | 93 | 18 | 46198 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1204 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | QIGYYRRATRRVRGGDGK | 84 | 101 | 18 | 51074 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1205 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | TRRVRGGDGKMKELSPRW | 92 | 109 | 18 | 66094 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1206 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GKMKELSPRWYFYYL | 100 | 114 | 15 | 20633 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1207 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | LSPRWYFYYLGTGPEASL | 105 | 122 | 18 | 39577 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1208 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YLGTGPEASLPYGANK | 113 | 128 | 16 | 74684 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1209 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | ANKEGIVWVATEGAL | 126 | 140 | 15 | 3324 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1210 | SARS-related coronavirus | SARS-related coronavirus | N | PKGFYAEGSRGGSQASSR | 169 | 186 | 18 | 48067 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1211 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MASGGGETALALLLLDRL | 211 | 228 | 18 | 41120 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1212 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | QQQGQTVTKKSAAEASKK | 241 | 258 | 18 | 52117 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1213 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SKKPRQKRTATKQYNV | 256 | 271 | 16 | 58868 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1214 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | KHWPQIAQFAPSASAFF | 300 | 316 | 17 | 31166 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1215 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | AFFGMSRIGMEVTPSGTW | 314 | 331 | 18 | 1295 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1216 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PQFKDNVILLNKHIDAYK | 345 | 362 | 18 | 48995 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1217 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | LLNKHIDAYKTFPPTEPK | 353 | 370 | 18 | 37611 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1218 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1219 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1220 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1221 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1222 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1223 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1224 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1225 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1226 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1227 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1228 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 19727132 |
| 1229 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1230 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1231 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GQGVPINTNSGPDDQ | 70 | 84 | 15 | 125079 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1232 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1233 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1234 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | PINTNSGPDDQIGYY | 74 | 88 | 15 | 125193 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1235 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1236 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1237 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | NSGPDDQIGYYRRAT | 78 | 92 | 15 | 125181 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1238 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1239 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1240 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | DDQIGYYRRATRRVR | 82 | 96 | 15 | 125005 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1241 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1242 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1243 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GYYRRATRRVRGGDG | 86 | 100 | 15 | 23508 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1244 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1245 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1246 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RATRRVRGGDGKMKE | 90 | 104 | 15 | 125228 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1247 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1248 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1249 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | RVRGGDGKMKELSPR | 94 | 108 | 15 | 125249 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1250 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1251 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1252 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | GDGKMKELSPRWYFY | 98 | 112 | 15 | 125060 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1253 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1254 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1255 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | MKELSPRWYFYYLGT | 102 | 116 | 15 | 125158 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1256 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1257 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1258 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | SPRWYFYYLGTGPEA | 106 | 120 | 15 | 60243 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1259 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-2 release | Mus musculus BALB/c | 19727132 |
| 1260 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | H2-d class II | II | Splenocyte | ELISPOT | IL-4 release | Mus musculus BALB/c | 19727132 |
| 1261 | SARS coronavirus Frankfurt 1 | SARS-related coronavirus | N | YFYYLGTGPEASL | 110 | 122 | 13 | 125322 | P59595 | - | - | Splenocyte | ELISPOT | IL-10 release | Mus musculus BALB/c | 19727132 |
| 1262 | SARS-related coronavirus | SARS-related coronavirus | N | ILLNKHID | 352 | 359 | 8 | 125100 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 1263 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 1264 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 1265 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 1266 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 1267 | SARS-related coronavirus | SARS-related coronavirus | N | LQLPQGTTL | 160 | 168 | 9 | 38881 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 1268 | SARS-related coronavirus | SARS-related coronavirus | N | ALNTPKDHI | 139 | 147 | 9 | 2802 | P59595 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 18708671 |
| 1269 | SARS-related coronavirus | SARS-related coronavirus | N | LALLLLDRL | 220 | 228 | 9 | 34851 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 1270 | SARS-related coronavirus | SARS-related coronavirus | N | LLLDRLNQL | 223 | 231 | 9 | 37473 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 1271 | SARS-related coronavirus | SARS-related coronavirus | N | GMSRIGMEV | 317 | 325 | 9 | 21347 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 1272 | SARS-related coronavirus | SARS-related coronavirus | N | RLNQLESKV | 227 | 235 | 9 | 54690 | P59595 | HLA-A*02:01 | I | T cell | in vitro assay | cytotoxicity | Mus musculus HLA-A2.1/Kb Tg | 18708671 |
| 1273 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 1274 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 1275 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | - | in vivo assay | pathogen burden after challenge | Mus musculus C57BL/6 | 18949029 |
| 1276 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 18949029 |
| 1277 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 1278 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 18949029 |
| 1279 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 1280 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus C57BL/6 | 18949029 |
| 1281 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 18949029 |
| 1282 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | IGNITLALGKVSNAITTTSD | 1089 | 1108 | 20 | 139083 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1283 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | GKVSNAITTTSDGFNSMASA | 1097 | 1116 | 20 | 139063 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1284 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | GKVSNAITTTSDGFNSMASA | 1097 | 1116 | 20 | 139063 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 1285 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | QSVVNQQGEALSQLTSQLQK | 1121 | 1140 | 20 | 139212 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1286 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | EALSQLTSQLQKNFQAISSS | 1129 | 1148 | 20 | 139032 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1287 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | QLQKNFQAISSSIAEIYNRL | 1137 | 1156 | 20 | 139206 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1288 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | YNRLEKVEADAQVDRLITGR | 1153 | 1172 | 20 | 139407 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1289 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | YNRLEKVEADAQVDRLITGR | 1153 | 1172 | 20 | 139407 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 1290 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ITGRLAALNAYVSQTLTQY | 1169 | 1187 | 19 | 139100 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1291 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | FSLVNSAPEGLLFFHTVLLPTEWEEVTA | 1222 | 1249 | 28 | 139054 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1292 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | FSLVNSAPEGLLFFHTVLLPTEWEEVTA | 1222 | 1249 | 28 | 139054 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 1293 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | WSGICVNDTYAYVLKDFDHSIFSYNGTY | 1250 | 1277 | 28 | 139392 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1294 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | TFQEIVIDYIDINKTIADML | 1312 | 1331 | 20 | 139313 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1295 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | YIDINKTIADMLEQYNPNYT | 1320 | 1339 | 20 | 139404 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1296 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ADMLEQYNPNYTTPELNLL | 1328 | 1346 | 19 | 138985 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1297 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | PNYTTPELNLLLDIFNQTKL | 1336 | 1355 | 20 | 139193 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 1298 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | EIDQLEQRADNLTTIAHELQ | 1360 | 1379 | 20 | 139034 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1299 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ADNLTTIAHELQQYIDNLNK | 1368 | 1387 | 20 | 138986 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1300 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | LDWLNRIETYVKWPWYVWLL | 1392 | 1411 | 20 | 139159 | P10033 | H2-d class II | II | Splenocyte | ELISA | IL-4 release | Mus musculus BALB/c | 21091984 |
| 1301 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | LDWLNRIETYVKWPWYVWLL | 1392 | 1411 | 20 | 139159 | P10033 | - | - | Splenocyte | ELISA | IFNg release | Mus musculus BALB/c | 21091984 |
| 1302 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20844028 |
| 1303 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20844028 |
| 1304 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 20844028 |
| 1305 | SARS coronavirus Urbani | SARS-related coronavirus | N | QFKDNVILL | 346 | 354 | 9 | 50779 | P59595 | HLA-A*24:02 | I | PBMC | CFSE | proliferation | Homo sapiens | 20844028 |
| 1306 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 1307 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 1308 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 1309 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 1310 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 1311 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus HLA-A*0201/Kb Tg | 20831383 |
| 1312 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 20831383 |
| 1313 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 20831383 |
| 1314 | SARS coronavirus TJF | SARS-related coronavirus | M | GLMWLSYFV | 88 | 96 | 9 | 21041 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20831383 |
| 1315 | SARS coronavirus TJF | SARS-related coronavirus | M | TLACFVLAAV | 60 | 69 | 10 | 64710 | P59596 | HLA-A*02:01 | I | T cell CD8+ | ELISPOT | IFNg release | Homo sapiens | 20831383 |
| 1316 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | NYVALQTDVLQENQKILANA | 1065 | 1084 | 20 | 139192 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1317 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | VLQENQKILANAFNNAIGNI | 1073 | 1092 | 20 | 139359 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1318 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | IGNITLALGKVSNAITTTSD | 1089 | 1108 | 20 | 139083 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1319 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | TTSDGFNSMASALTKIQSVV | 1105 | 1124 | 20 | 139330 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1320 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ITGRLAALNAYVSQTLTQY | 1169 | 1187 | 19 | 139100 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1321 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | FSLVNSAPEGLLFFHTVLLPTEWEEVTA | 1222 | 1249 | 28 | 139054 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1322 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | QALSHLTVQLQNNFQAISSS | 1115 | 1134 | 20 | 142260 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1323 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | ISSSISDIYNRLDELSADAQ | 1131 | 1150 | 20 | 142189 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1324 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | ITGRLTALNAFVSQTLTRQA | 1155 | 1174 | 20 | 142190 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1325 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | FSLANAAPNGMIFFHTVLLPTAYETVTAW | 1208 | 1236 | 29 | 142156 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1326 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | WSGICASDGDRTFGLVVKDVQLTLFRNLDDKF | 1236 | 1267 | 32 | 142331 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1327 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | EIDDLEFRSEKLHNTTVELA | 1348 | 1367 | 20 | 142140 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1328 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NINNTLVNLEWLNRIETYVK | 1372 | 1391 | 20 | 142240 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1329 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | YVCPRDFVPKGIGNKDQQIG | 49 | 68 | 20 | 142341 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1330 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | YVCPRDFVPKGIGNKDQQIG | 49 | 68 | 20 | 142341 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1331 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | GQRKELPERWFFYFLGTGPH | 81 | 100 | 20 | 142171 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1332 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | GQRKELPERWFFYFLGTGPH | 81 | 100 | 20 | 142171 | P25909 | H2 class I | I | T cell CD8+ | ELISA | IFNg release | Felis catus | 21216312 |
| 1333 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | EPLRFDGKIPPQFQLEVNRS | 137 | 156 | 20 | 142145 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1334 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | EPLRFDGKIPPQFQLEVNRS | 137 | 156 | 20 | 142145 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1335 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | IPPQFQLEVNRSRNNSRSGS | 145 | 164 | 20 | 142187 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1336 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | IPPQFQLEVNRSRNNSRSGS | 145 | 164 | 20 | 142187 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1337 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | DVTNFFGARSASANFGDSDL | 241 | 260 | 20 | 142133 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1338 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | IAECVPSVSSVLFGSQWSAE | 273 | 292 | 20 | 142182 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1339 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | AKTSQFLEQIDAYKRPSQVA | 313 | 332 | 20 | 142110 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1340 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | SVTLVEAYTDVFDDTQVEMI | 353 | 372 | 20 | 142304 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21216312 |
| 1341 | SARS-related coronavirus | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20610717 |
| 1342 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20610717 |
| 1343 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 20610717 |
| 1344 | SARS-related coronavirus | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNF release | Mus musculus C57BL/6 | 20610717 |
| 1345 | SARS-related coronavirus | SARS-related coronavirus | S | YNYKYRYL | 436 | 443 | 8 | 75237 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 20610717 |
| 1346 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNF release | Mus musculus C57BL/6 | 20610717 |
| 1347 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 20610717 |
| 1348 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | TNF release | Mus musculus BALB/c | 20610717 |
| 1349 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus BALB/c | 20610717 |
| 1350 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 20610717 |
| 1351 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 20610717 |
| 1352 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 20610717 |
| 1353 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | ICS | TNF release | Mus musculus BALB/c | 20610717 |
| 1354 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 20610717 |
| 1355 | SARS-related coronavirus | SARS-related coronavirus | S | CYGVSATKL | 366 | 374 | 9 | 7382 | P59594 | H2-d class I | I | T cell CD8+ | in vivo assay | cytotoxicity | Mus musculus BALB/c | 20610717 |
| 1356 | Feline coronavirus | Alphacoronavirus 1 | N | RLGVTSDNKQ | 199 | 208 | 10 | 144946 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 21376481 |
| 1357 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 21525347 |
| 1358 | Murine hepatitis virus | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IL-10 release | Mus musculus C57BL/6 | 21525347 |
| 1359 | Murine hepatitis virus | Murine coronavirus | S | TTYDLRCL | 532 | 539 | 8 | 147348 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 1360 | Murine hepatitis virus | Murine coronavirus | S | RCHIFSNLL | 587 | 595 | 9 | 147241 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 1361 | Murine hepatitis virus | Murine coronavirus | S | LTTFEPFTVSIVNDS | 766 | 780 | 15 | 147122 | P11224 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 1362 | Murine hepatitis virus | Murine coronavirus | S | IDDINFSPLLGCLGS | 881 | 895 | 15 | 147025 | P11224 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 1363 | Murine hepatitis virus | Murine coronavirus | S | LSDVGFVEAYNNCTG | 921 | 935 | 15 | 147114 | P11224 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 1364 | Murine hepatitis virus | Murine coronavirus | S | GGNSIIGFWHTDIKS | 171 | 185 | 15 | 146966 | P11224 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 1365 | Murine hepatitis virus | Murine coronavirus | S | VGLVYRRV | 317 | 324 | 8 | 147369 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 1366 | Murine hepatitis virus | Murine coronavirus | S | SLLRFVQAESLSCSN | 361 | 375 | 15 | 147293 | P11224 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 1367 | Murine hepatitis virus | Murine coronavirus | N | DVYELQYSGAIRFDS | 346 | 360 | 15 | 146856 | P03416 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 1368 | Murine hepatitis virus | Murine coronavirus | N | LDAYQDQAGGADVVS | 376 | 390 | 15 | 147085 | P03416 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 1369 | Murine hepatitis virus | Murine coronavirus | N | QRNVSREL | 421 | 428 | 8 | 147235 | P03416 | H2-Dk | I | T cell CD8+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 1370 | Murine hepatitis virus | Murine coronavirus | M | KGTVYVRPIIEDYHT | 131 | 145 | 15 | 147062 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 1371 | Murine hepatitis virus | Murine coronavirus | M | CTYKRAFL | 184 | 191 | 8 | 146810 | P03415 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 20554960 |
| 1372 | Murine hepatitis virus | Murine coronavirus | M | GVSGFAVYVKSKVGN | 196 | 210 | 15 | 147006 | P03415 | H2-IEk | II | T cell CD4+ | ICS | IFNg release | Mus musculus C3H/He | 20554960 |
| 1373 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus SJL | 16981179 |
| 1374 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | T cell CD4+ | ELISA | IFNg release | Mus musculus SJL | 16981179 |
| 1375 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus SJL | 16981179 |
| 1376 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | TMLSLATAKVIAKWLAVNVLYFTDVPQIKL | 3811 | 3840 | 30 | 149122 | P0C6X9 | H2-s class II | II | T cell CD4+ | 3H-thymidine | proliferation | Mus musculus SJL | 16981179 |
| 1377 | Murine hepatitis virus | Murine coronavirus | ORF 1ab | KVIAKWLAVNVL | 3819 | 3830 | 12 | 34033 | P0C6X9 | H2-s class II | II | - | in vivo skin test | type IV hypersensitivity (DTH) | Mus musculus SJL | 16981179 |
| 1378 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1379 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1380 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | AFLAVFQSATKIIAL | 51 | 65 | 15 | 156841 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1381 | SARS-related coronavirus | SARS-related coronavirus | N | TPSGTWLTYHGAIKL | 326 | 340 | 15 | 65764 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1382 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | GVKDYVVVHGYFTEV | 196 | 210 | 15 | 156880 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1383 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | YFTEVYYQLESTQIT | 206 | 220 | 15 | 156976 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1384 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | NKRWQLALYKGFQFI | 66 | 80 | 15 | 156921 | P59632 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1385 | SARS-related coronavirus | SARS-related coronavirus | N | IGMEVTPSGTWLTYH | 321 | 335 | 15 | 26273 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1386 | SARS-related coronavirus | SARS-related coronavirus | N | ANKEGIVWVATEGAL | 126 | 140 | 15 | 3324 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1387 | SARS-related coronavirus | SARS-related coronavirus | N | AQFAPSASAFFGMSR | 306 | 320 | 15 | 3957 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1388 | SARS-related coronavirus | SARS-related coronavirus | N | RRPQGLPNNTASWFT | 41 | 55 | 15 | 55683 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1389 | SARS-related coronavirus | SARS-related coronavirus | N | KMKELSPRWYFYYLG | 101 | 115 | 15 | 32340 | P59595 | HLA class II | II | T cell CD4+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1390 | SARS-related coronavirus | SARS-related coronavirus | N | QKRTATKQYNVTQAF | 261 | 275 | 15 | 51250 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1391 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 21813600 |
| 1392 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | TNFa release | Homo sapiens | 21813600 |
| 1393 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | IL-2 release | Homo sapiens | 21813600 |
| 1394 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | CCL3/MIP-1a release | Homo sapiens | 21813600 |
| 1395 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | CCL4/MIP-1b release | Homo sapiens | 21813600 |
| 1396 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | GM-CSF release | Homo sapiens | 21813600 |
| 1397 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | TNFa release | Homo sapiens | 21813600 |
| 1398 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | CCL3/MIP-1a release | Homo sapiens | 21813600 |
| 1399 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | CCL4/MIP-1b release | Homo sapiens | 21813600 |
| 1400 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IL-2 release | Homo sapiens | 21813600 |
| 1401 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 21813600 |
| 1402 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 21813600 |
| 1403 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | GM-CSF release | Homo sapiens | 21813600 |
| 1404 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IL-8 release | Homo sapiens | 21813600 |
| 1405 | Murine hepatitis virus strain A59 | Murine coronavirus | S | RCQIFANI | 546 | 553 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 14722270 |
| 1406 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFFGSKLELVKK | 318 | 335 | 18 | 156540 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7815531 |
| 1407 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | - | in vivo assay | survival from challenge | Mus musculus BALB/c | 7815531 |
| 1408 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA class II | II | T cell CD4+ | ICS | IL-8 release | Homo sapiens | 21813600 |
| 1409 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFFGSKLELVKK | 318 | 335 | 18 | 156540 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 7815531 |
| 1410 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFFF | 318 | 326 | 9 | 3840 | P03416 | H2-Ld | I | - | in vivo assay | pathogen burden after challenge | Mus musculus BALB/c | 7815531 |
| 1411 | SARS-related coronavirus | SARS-related coronavirus | S | KCYGVSATKL | 365 | 374 | 10 | 30098 | P59594 | H2-Kd | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 22963340 |
| 1412 | SARS-related coronavirus | SARS-related coronavirus | S | YGVSATKL | 367 | 374 | 8 | 181163 | P59594 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 22963340 |
| 1413 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 22105170 |
| 1414 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 22105170 |
| 1415 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | - | in vivo assay | cytotoxicity | Mus musculus C57BL/6 | 22105170 |
| 1416 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-Kb | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 22915814 |
| 1417 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-Kb | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 22915814 |
| 1418 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IFNg release | Mus musculus C57BL/6 | 23928495 |
| 1419 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 23928495 |
| 1420 | Murine hepatitis virus strain JHM | Murine coronavirus | M | TVYVRPIIEDYHTLT | 133 | 147 | 15 | 67241 | P03415 | H2-IAb | II | T cell CD4+ | ICS | IL-10 release | Mus musculus C57BL/6 | 23928495 |
| 1421 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 23280567 |
| 1422 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 23280567 |
| 1423 | SARS-related coronavirus | SARS-related coronavirus | N | MEVTPSGTWL | 323 | 332 | 10 | 190494 | P59595 | HLA-B*40:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 23280567 |
| 1424 | SARS-related coronavirus | SARS-related coronavirus | N | MEVTPSGTWL | 323 | 332 | 10 | 190494 | P59595 | HLA-B*40:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 23280567 |
| 1425 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | SITAQPVKI | 12 | 20 | 9 | 193551 | P59632 | HLA-B*58:01 | I | T cell CD8+ | multimer/tetramer | qualitative binding | Homo sapiens | 23280567 |
| 1426 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | SITAQPVKI | 12 | 20 | 9 | 193551 | P59632 | HLA-B*58:01 | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 23280567 |
| 1427 | SARS-related coronavirus | SARS-related coronavirus | N | GETALALLLL | 216 | 225 | 10 | 19442 | P59595 | HLA-B*40:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 1428 | SARS-related coronavirus | SARS-related coronavirus | N | MEVTPSGTWL | 323 | 332 | 10 | 190494 | P59595 | HLA-B*40:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 1429 | SARS-related coronavirus | SARS-related coronavirus | ORF 3a | RFFTLGSITAQPVKI | 6 | 20 | 15 | 156949 | P59632 | HLA-B*58:01 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 1430 | SARS-related coronavirus | SARS-related coronavirus | N | RRPQGLPNNIASWFT | 41 | 55 | 15 | 190533 | P59595 | HLA-B*55:02 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 1431 | SARS-related coronavirus | SARS-related coronavirus | N | QKRTATKQYNVTQAF | 261 | 275 | 15 | 51250 | P59595 | HLA-B*15:25 | I | T cell | ELISPOT | IFNg release | Homo sapiens | 24058176 |
| 1432 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | GHFYINGYNFFSTFPIGCIS | 431 | 450 | 20 | 226034 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1433 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | SVVLLPSFFTYTAVNITIDL | 521 | 540 | 20 | 226106 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1434 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | YTAVNITIDLGMKLSGYGQP | 531 | 550 | 20 | 226133 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1435 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | CIRSNQFSVYVHSTCKSSLW | 571 | 590 | 20 | 226011 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1436 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | GTCPFSFDKLNNYLTFNKFC | 611 | 630 | 20 | 226038 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1437 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NNYLTFNKFCLSLSPVGANC | 621 | 640 | 20 | 226076 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1438 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NEQVVRSLYVIYEEGDNIVG | 651 | 670 | 20 | 226074 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1439 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | MKYVVFILACILACAFGERY | 1 | 20 | 20 | 226071 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1440 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VILIVFITVLQYGRPQFSWL | 61 | 80 | 20 | 226118 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1441 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | QYGRPQFSWLVYGIKMLIMW | 71 | 90 | 20 | 226093 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1442 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | IFNAYSEYQVSRYVMFGFSV | 101 | 120 | 20 | 226043 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1443 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | MMYFVRSIQLYRRTKSWWSF | 131 | 150 | 20 | 226072 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1444 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | YRRTKSWWSFNPETNAILCV | 141 | 160 | 20 | 226132 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1445 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | NPETNAILCVNAVGRSYVLP | 151 | 170 | 20 | 226077 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1446 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | NAVGRSYVLPLDGTPTGVTL | 161 | 180 | 20 | 226073 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1447 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | LDGTPTGVTLTLLSGNLYAE | 171 | 190 | 20 | 226059 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1448 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | TLLSGNLYAEGFKMAGGLTI | 181 | 200 | 20 | 226112 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1449 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | EHLPKYVMIATPSRTIVYTL | 201 | 220 | 20 | 226017 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1450 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | TPSRTIVYTLVGKQLKATTA | 211 | 230 | 20 | 226114 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1451 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | QYGRPQFSWLVYGIKMLIMW | 71 | 90 | 20 | 226093 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1452 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | IFNAYSEYQVSRYVMFGFSV | 101 | 120 | 20 | 226043 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1453 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | MMYFVRSIQLYRRTKSWWSF | 131 | 150 | 20 | 226072 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1454 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | IGNITLALGKVSNAITTTSD | 1089 | 1108 | 20 | 139083 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1455 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | S | ITGRLAALNAYVSQTLTQY | 1169 | 1187 | 19 | 139100 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1456 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | HLANWNFSWSVILIVFITVL | 51 | 70 | 20 | 226041 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1457 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VYGIKMLIMWLLWPIVLALT | 81 | 100 | 20 | 226128 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1458 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | SRYVMFGFSVAGAVVTFALW | 111 | 130 | 20 | 226103 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1459 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | AGAVVTFALWMMYFVRSIQL | 121 | 140 | 20 | 226001 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1460 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | GHFYINGYNFFSTFPIGCIS | 431 | 450 | 20 | 226034 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1461 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NNYLTFNKFCLSLSPVGANC | 621 | 640 | 20 | 226076 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1462 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | HLANWNFSWSVILIVFITVL | 51 | 70 | 20 | 226041 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1463 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VYGIKMLIMWLLWPIVLALT | 81 | 100 | 20 | 226128 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1464 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | SRYVMFGFSVAGAVVTFALW | 111 | 130 | 20 | 226103 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1465 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | AGAVVTFALWMMYFVRSIQL | 121 | 140 | 20 | 226001 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1466 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | GQRKELPERWFFYFLGTGPH | 81 | 100 | 20 | 142171 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1467 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | N | EPLRFDGKIPPQFQLEVNRS | 137 | 156 | 20 | 142145 | P25909 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1468 | Feline infectious peritonitis virus (strain 79-1146) | Alphacoronavirus 1 | S | NNYLTFNKFCLSLSPVGANC | 621 | 640 | 20 | 226076 | P10033 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1469 | Feline infectious peritonitis virus (strain KU-2) | Alphacoronavirus 1 | M | VYGIKMLIMWLLWPIVLALT | 81 | 100 | 20 | 226128 | P25878 | - | - | PBMC | ELISA | IFNg release | Felis catus | 24530149 |
| 1470 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 1471 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 1472 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 1473 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 1474 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 1475 | Murine hepatitis virus strain JHM | Murine coronavirus | S | RCQIFANI | 457 | 464 | 8 | 53307 | P11224 | H2-Kb | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 24795457 |
| 1476 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 1477 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 1478 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 1479 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 25056892 |
| 1480 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 1481 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IL-2 release | Mus musculus C57BL/6 | 25056892 |
| 1482 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25056892 |
| 1483 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25056892 |
| 1484 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 1485 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25056892 |
| 1486 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 1487 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus C57BL/6 | 25056892 |
| 1488 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | intracellular staining | granzyme B release | Mus musculus C57BL/6 | 25056892 |
| 1489 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | T cell CD8+ | in vivo assay | cytotoxicity | Mus musculus C57BL/6 | 25056892 |
| 1490 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | intracellular staining | granzyme B release | Mus musculus C57BL/6 | 25056892 |
| 1491 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | T cell CD8+ | in vivo assay | cytotoxicity | Mus musculus C57BL/6 | 25056892 |
| 1492 | SARS-related coronavirus | SARS-related coronavirus | S | HNYKYRYL | 436 | 443 | 8 | 187223 | P59594 | H2-b class I | I | - | in vivo assay | survival from challenge | Mus musculus C57BL/6 | 25056892 |
| 1493 | SARS-related coronavirus | SARS-related coronavirus | S | VNFNFNGL | 525 | 532 | 8 | 70066 | P59594 | H2-b class I | I | - | in vivo assay | survival from challenge | Mus musculus C57BL/6 | 25056892 |
| 1494 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25135637 |
| 1495 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25135637 |
| 1496 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL + (C1) | 510 | 518 | 16 | 422251 | P11224 | H2-Db | I | T cell CD8+ | ICS | IFNg release | Mus musculus C57BL/6 | 25135637 |
| 1497 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL | 510 | 518 | 9 | 7032 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25135637 |
| 1498 | Murine hepatitis virus strain JHM | Murine coronavirus | S | CSLWNGPHL + (C1) | 510 | 518 | 16 | 422251 | P11224 | H2-Db | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus C57BL/6 | 25135637 |
| 1499 | Infectious bronchitis virus | Avian coronavirus | S | SRIQTATDP | 412 | 420 | 9 | 502625 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 1500 | Infectious bronchitis virus | Avian coronavirus | S | SRNATGSQP | 516 | 524 | 9 | 502630 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 1501 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | GAYAVVNV | 45 | 52 | 8 | 499027 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 1502 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | SRIQTATQP | 413 | 421 | 9 | 502627 | P11223 | - | - | Splenocyte | ELISPOT | IFNg release | Gallus gallus | 26620841 |
| 1503 | Infectious bronchitis virus | Avian coronavirus | S | SRIQTATDP | 412 | 420 | 9 | 502625 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 1504 | Infectious bronchitis virus | Avian coronavirus | S | SRNATGSQP | 516 | 524 | 9 | 502630 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 1505 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | GAYAVVNV | 45 | 52 | 8 | 499027 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 1506 | Avian infectious bronchitis virus (strain Holte) | Avian coronavirus | S | SRIQTATQP | 413 | 421 | 9 | 502627 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus | 26620841 |
| 1507 | Infectious bronchitis virus | Avian coronavirus | S | NQFYIKLT | 527 | 534 | 8 | 509285 | P11223 | chicken class I | I | T cell CD8+ | CFSE | proliferation | Gallus gallus H.B15 | 26876645 |
| 1508 | Infectious bronchitis virus | Avian coronavirus | S | NQFYIKLT | 527 | 534 | 8 | 509285 | P11223 | chicken class I | I | T cell CD8+ | RNA/DNA detection | IFNg release | Gallus gallus H.B15 | 26876645 |
| 1509 | SARS-related coronavirus | SARS-related coronavirus | N | KMKELSPRWYFYYLG | 101 | 115 | 15 | 32340 | P59595 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 1510 | SARS-related coronavirus | SARS-related coronavirus | M | HLRMAGHSL | 147 | 155 | 9 | 532115 | P59596 | HLA class I | I | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 1511 | SARS-related coronavirus | SARS-related coronavirus | S | STDLIKNQCVNFNFN | 516 | 530 | 15 | 61554 | P59594 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 1512 | SARS-related coronavirus | SARS-related coronavirus | S | SSKRFQPFQQFGRDV | 541 | 555 | 15 | 533900 | P59594 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 1513 | SARS-related coronavirus | SARS-related coronavirus | S | GTSWFITQRNFFSPQ | 1081 | 1095 | 15 | 532052 | P59594 | HLA class II | II | PBMC | ELISPOT | IFNg release | Homo sapiens | 26954467 |
| 1514 | SARS-related coronavirus | SARS-related coronavirus | M | HLRMAGHSL | 147 | 155 | 9 | 532115 | P59596 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 26954467 |
| 1515 | SARS-related coronavirus | SARS-related coronavirus | N | TKQYNVTQAF | 266 | 275 | 10 | 534068 | P59595 | HLA class I | I | T cell CD8+ | ICS | IFNg release | Homo sapiens | 26954467 |
| 1516 | SARS-related coronavirus | SARS-related coronavirus | N | TKQYNVTQAF | 266 | 275 | 10 | 534068 | P59595 | HLA class I | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 26954467 |
| 1517 | SARS-related coronavirus | SARS-related coronavirus | M | HLRMAGHSL | 147 | 155 | 9 | 532115 | P59596 | HLA class I | I | T cell CD8+ | biological activity | degranulation | Homo sapiens | 26954467 |
| 1518 | Murine hepatitis virus strain JHM | Murine coronavirus | N | GPTKDVYEL | 342 | 350 | 9 | 21808 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 1519 | Murine hepatitis virus strain JHM | Murine coronavirus | N | PTAGAFFF | 319 | 326 | 8 | 745623 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 1520 | Murine hepatitis virus strain JHM | Murine coronavirus | N | TAGAFFF | 320 | 326 | 7 | 745653 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 1521 | Murine hepatitis virus strain JHM | Murine coronavirus | N | APTAGAFF | 318 | 325 | 8 | 745560 | P03416 | H2-Ld | I | T cell CD8+ | 51 chromium | cytotoxicity | Mus musculus BALB/c | 8627807 |
| 1522 | MERS-related coronavirus | MERS-related coronavirus | S | SFYAPEPITSL | 1190 | 1200 | 11 | 625112 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1523 | MERS-related coronavirus | MERS-related coronavirus | S | FYAPEPITSL | 1191 | 1200 | 10 | 616629 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1524 | MERS-related coronavirus | MERS-related coronavirus | S | FYAPEPITS | 1191 | 1199 | 9 | 616628 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1525 | MERS-related coronavirus | MERS-related coronavirus | S | SFYAPEPIT | 1190 | 1198 | 9 | 625111 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1526 | MERS-related coronavirus | MERS-related coronavirus | S | SFYAPEPI | 1190 | 1197 | 8 | 625110 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1527 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHSI | 292 | 300 | 9 | 628707 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1528 | MERS-related coronavirus | MERS-related coronavirus | S | KYYSIIPHSI | 291 | 300 | 10 | 620933 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1529 | MERS-related coronavirus | MERS-related coronavirus | S | KYYSIIPHS | 291 | 299 | 9 | 620932 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1530 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHS | 292 | 299 | 8 | 628706 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1531 | MERS-related coronavirus | MERS-related coronavirus | S | FAQSIFYRL | 972 | 980 | 9 | 616139 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1532 | MERS-related coronavirus | MERS-related coronavirus | S | FYRLNGVGI | 977 | 985 | 9 | 616635 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1533 | MERS-related coronavirus | MERS-related coronavirus | S | FYRLNGVGIT | 977 | 986 | 10 | 616636 | 667489389 | H2-Kd | I | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 27903740 |
| 1534 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHSI | 292 | 300 | 9 | 628707 | 667489389 | H2-Kd | I | T cell CD8+ | multimer/tetramer | qualitative binding | Mus musculus BALB/c | 27903740 |
| 1535 | MERS-related coronavirus | MERS-related coronavirus | S | YYSIIPHSI | 292 | 300 | 9 | 628707 | 667489389 | H2-Kd | I | - | in vivo assay | protection from challenge | Mus musculus BALB/c | 27903740 |
| 1536 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | - | - | Splenocyte | ELISPOT | IFNg release | Mus musculus BALB/c | 28579232 |
| 1537 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 28579232 |
| 1538 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus BALB/c | 28579232 |
| 1539 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IL-17 release | Mus musculus BALB/c | 28579232 |
| 1540 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 28579232 |
| 1541 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | TNFa release | Mus musculus BALB/c | 28579232 |
| 1542 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ICS | IL-17 release | Mus musculus BALB/c | 28579232 |
| 1543 | MERS-related coronavirus | MERS-related coronavirus | S | VYDTIKYYSIIPHSI | 286 | 300 | 15 | 871495 | 667489389 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 28579232 |
| 1544 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | QNIDAYKTFPKKEKK | 353 | 367 | 15 | 862950 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1545 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKEKKQKAP | 357 | 371 | 15 | 862444 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1546 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKEKK | 357 | 367 | 11 | 862443 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1547 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKEK | 357 | 366 | 10 | 862442 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1548 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKKE | 357 | 365 | 9 | 862441 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1549 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | YKTFPKKEK | 358 | 366 | 9 | 863259 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1550 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | KTFPKKEKK | 359 | 367 | 9 | 862768 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1551 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | AYKTFPKK | 357 | 364 | 8 | 862440 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1552 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | YKTFPKKE | 358 | 365 | 8 | 863258 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1553 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | KTFPKKEK | 359 | 366 | 8 | 862767 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1554 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | TFPKKEKK | 360 | 367 | 8 | 863104 | 667489396 | H2-d class I | I | T cell CD8+ | ELISPOT | IFNg release | Mus musculus BALB/c | 30558354 |
| 1555 | Human betacoronavirus 2c EMC/2012 | MERS-related coronavirus | N | YKTFPKKEKK | 358 | 367 | 10 | 863260 | 667489396 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 30558354 |
| 1556 | SARS coronavirus Urbani | SARS-related coronavirus | N | PDDQIGYYRRATRRV | 81 | 95 | 15 | 47074 | P59595 | H2-d class I | I | T cell CD8+ | ICS | IFNg release | Mus musculus BALB/c | 16494977 |